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An antitumor and immunopotentiating polysaccharide-protein complex 
(PSPC) was isolated and characterized from the culture filtrates of Tricholoma 
lobayense Heim which was a new record of mushroom species found in Hong 
Kong. PSPC could inhibit the growth of Sarcoma 180 implanted in mice 
intraperitoneally and subcutaneously, with no sign of toxicity in vivo. In addition, 
it also exhibited antimicrobial, free radical scavenging and antifatigue activities. 
PSPC was not a glucan-protein complex, but rather it was present as a 
heteroglycan-protein complex, with a molecular mass estimated to be 154 kDa by 
gel filtration. It contained 54.3% polysaccharide which consisted of galactose, 
glucose, arabinose, xylose, rhamnose, fucose and mannose, and 35.9% protein 
which was composed of predominantly acidic amino acids such as aspartic acid 
and glutamic acid. The infrared spectra of PSPC showed that PSPC had the 
characteristic primary molecular groups of polysaccharide and intermolecular 
hydrogen bonds. The polysaccharide peak of PSPC coincided with its protein 
peak on DEAE-cellulose and gel filtration columns. The polysaccharide and 
protein bands ofPSPC were located on the same spot on SDS-polyacrylamide gel 
electrophoresis. Therefore, PSPC behaved as a protein-bound polysaccharide. 
PSPC could significantly restore and increase the phagocytic function of 
peritoneal exudate cells (PEC) and the mitogenic activity o f T cells ofthe tumor-
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bearing mice. It also exhibited indirect cytotoxicity against P815 mouse monocyte-
macrophages and L929 mouse fibroblast cells by activating PEC to release the 
mediators, such as nitric oxide and TNF-a. Electron microscopic observation on 
tumor regression showed that PSPC indirectly induced Sarcoma 180 apoptosis in 
vivo, and directly induced human leukemia cells (HL-60) apoptosis in vitro. PSPC 
also had antiproliferative activities against some tumor cell lines in vitro, such as 
PU5-1.8 mouse monocyte-macrophages, H3B hepatoma cells and melanoma cells. 
Therefore, the antitumor activity of PSPC might be due to both host-mediated 
immunomodulating action and direct cytotoxicity. 
At the molecular level, the gene expression of seventeen cytokines and six 
cytokine receptors potentiated by PSPC was analyzed using reverse transcription-
polymerase chain reaction (RT-PCR) and dot-blot hybridization. The results 
showed that nine out of seventeen cytokine mRNAs and five out of six cytokine 
receptor mRNAs were detected in the splenocytes and PEC of both the control 
and treated mice. However, JL-4 was only detected in the splenocytes while JL-7 
and IL-lR(I) were only detected in PEC. Among nine cytokine genes, the 
expression level of M-CSF was up-regulated in the splenocytes and PEC of the 
mice by PSPC. The mRNA level of TGF-P which was related to 
immunosuppression in the tumor-bearing mice was higher than that of the normal 
mice. Thus, it is suggested that the antitumor mechanism ofPSPC might also be 
via cytokine potentiation pathways. 
PSPC had the potent antimicrobial activity against Escherichia coli B and 
Staphylococcus aureus probably by the activation of phagocytic function and nitric 
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oxide production of macrophages in vivo. The activities of superoxide and 
hydroxyl radical scavenging of PSPC were investigated using phenazin 
methosulphate-NADH-nitroblue tetrazolium system and vitamin C-Cu^^-
cytochrome C system respectively. The results showed that PSPC had the 
scavenging activities on superoxide and hydroxyl radicals generated by these two 
systems. PSPC was also found to have antifatigue effect since it could increase the 
stamina ofthe treated mice. However, PSPC did not exhibit any antioxidative and 
hepatic protective effects. 
In brief, the antitumor activity ofPSPC seems to be attributed, at least in 
part, to the host-mediated immunomodulation. The influence of PSPC on gene 
expression of cytokines could play a role in this aspect. PSPC also demonstrates 
significant antimicrobial, free radical scavenging and antifatigue activities. PSPC 
has thus the potential for development as a nutriceutical or as an adjuvant 
antitumor agent. 
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Tricholoma lohayense Heim is a new record of mushroom species found in 
Hong Kong (Chang and Mao, 1995). It is an edible mushroom belonging to 
Tricholoma, Tricholomatacease, Agaricales, Hymenomycetes and 
Basidiomycotina. It is a tropical or subtropical mushroom discovered in China, 
India, Africa and Japan. In Hong Kong, T. lohayense can be found on the campus 
of the Chinese University of Hong Kong. Some biological characteristics of T. 
lohayense have been investigated in Nigeria. For example, amatoxin spot test and 
chromatographic screening of T. lohayense reveal the absence of amatoxins and 
phallotoxins (Fasidi and Kadiri, 1995). Saponins and flavonoids are also absent in 
T. lohayense while alkaloids, tannins and anthraquinones are present in low 
quantities (Kadiri and Fasidi, 1992). T. lohayense contains all the essential amino 
acids in varying amounts and the most abundant ones are glycine, glutamate, 
alanine and aspartate. Four trace minerals, namely chromium, cobalt, nickel and 
zinc are found in T. lohayense. Zinc is found to be five times more abundant than 
the other three minerals (Alofe, 1991). 
1 
The biological activity of various species of genus Tricholoma has been 
studied in Japan, China and Italy. It is found that polysaccharides from the fruiting 
body of T. matsutake (Chihara, 1992) and T. giganteum (Mizuno et aI, 1995a) 
have antitumor activity. However, the composition of antitumor polysaccharide 
from T. giganteum is obviously different from those commercially available 
antitumor polysaccharides such as PSK from the cultured mycelia of Coriolus 
versicolor (Tsukagoshi et al., 1984)，lentinan from the fruiting body of Lentinus 
edodes (Chihara et al., 1969; Chihara et al., 1970a) and schizophyllan from the 
culture filtrates of Schizophyllum commune (Komatsu et al., 1969; Tabata et al., 
1981). The polysaccharide moiety of these three antitumor agents belongs to P_ 
glucan while the antitumor polysaccharide from T. giganteum is heteroglycan. 
However, the antitumor components of T. giganteum are similar to PSK, and they 
are all protein-containing polysaccharides (Mizono et al., 1995a). A more recent 
report shows that two distinct lectins from the cultured mycelia of T. mongolicum 
have antitumor and other biological activities (Wang et al., 1995; Wang et al., 
1996). These two lectins contain only protein, but no sugar. In addition, it is found 
that the extracts of mycelia and culture filtrates from T. nudum have antimicrobial 
activity against Escherichia coli, Klebsiella pneumoniae. Bacillus subtilis and 
Staphylococcus aureus (Coletto, 1992), and those from T. rohustum exhibit 
antimicrobial activity against Staphylococcus aureus (Coletto et al., 1993). 
Therefore, genus Tricholoma provides a promising source for development of 
potential medicinal and therapeutic agents. 
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Hong Kong is rich in mushroom resource. It is very significant to exploit 
and study the local natural resources. The fruiting body of T. lohayense is 
collected on the campus of the Chinese University of Hong Kong (Chang and 
Mao, 1995). At present, although the fruiting body of this mushroom can not be 
cultivated artificially, its mycelia have been successfully cultured in our laboratory. 
The crude extracts (cultured mycelia and culture filtrates) of T. lohayense are 
screened and studied along with other mushroom species for their potential 
medicinal values. The preliminary results show that its crude extracts have 
significant antitumor activity and some other promising biological properties. 
Therefore, T. lohayense is used as the research strain of mushroom for my Ph.D 
research program. 
The polysaccharide extracts from T. lohayense were isolated from cultured 
mycelia and culture filtrates respectively in order to search for the antitumor and 
other biologically active components. Antitumor assay of the polysaccharide 
extracts obtained demonstrated that the antitumor components might mainly derive 
from the culture filtrates of T. lohayense. 
The polysaccharide extracts from the culture filtrates of T. lohayense were 
purified using DEAE-cellulose ion exchange chromatography. Of its two sub-
fractions, A-1 and A-2, only the latter shows antitumor activity. Fraction A-2 is a 
polysaccharide-protein complex, designated PSPC. 
Antitumor activity of PSPC was assayed by using the tumor cell lines 
Sarcoma 180 in ICR and BALB/c mice because the allogeneic Sarcoma 180 is 
generally used as the basic screening model. Besides antitumor activity, the other 
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biological activities of PSPC such as antimicrobial, antifatigue, free radical 
scavenging and hepatic protective activities, were also investigated in my research. 
Although PSPC has various biological activities, antitumor activity is the 
most promising one. However, antitumor mechanism of polysaccharides is still not 
completely understood. It is widely accepted that antitumor components from 
mushrooms enhance various immune responses in vivo and in vitro (Tsukagoshi et 
al., 1984; Chihara, 1992). Moreover, it is suggested that cell-mediated immune 
response plays an important role in antitumor activity of polysaccharides because 
the presence of tumor leads to in vivo immunosuppression (Dye and North, 1981; 
Suzuki et al., 1994). Therefore, the effects ofPSPC on the peritoneal exudate cells 
(PEC) and T cells of the normal and tumor-bearing mice are assessed by the 
detection of phagocytic function and mitogenic activity. The products of PEC 
such as nitric oxide (NO) and tumor-necrosis factor-a (TNF-a) are also measured 
after PSPC treatment in the mice because NO and TNF-a may directly affect on 
the growth ofP815 mastocytoma cells and L929 mouse fibroblast cells (Keller et 
al., 1990). Moreover, some protein-bound polysaccharides from Coriolus 
versicolor, for example, PSK known in Japan (Tsukagoshi et al., 1984)，PSP 
known in China (Yang et al., 1992) are reported to be able to directly inhibit the 
growth and DNA synthesis of tumor cell lines in vitro. The lectins from Grifola 
frondosa (Kawagishi et al., 1990b) and T. mongolicum (Wang et al., 1995) also 
have direct cytotoxicity to tumor cell lines in vitro. Therefore, in the present 
investigation, the antiproliferative activity ofPSPC was studied in tumor cell lines 
such as PU5-1.8 (mouse monocyte-macrophage), H3B (hepatoma cell) and 
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melanoma in vitro. In addition, the regressive modes of Sarcoma 180 in vivo and 
human leukemia cells (HL-60) in vitro induced by PSPC were observed using 
transmission electron microscopy to analyze the aspects of apoptosis in antitumor 
mechanism ofPSPC. 
During the development of polysaccharides as antitumor agents, many 
studies have been carried out and many modes of immunomodulation, especially at 
the cellular level, have been proposed. However, molecular biological 
characterization of the antitumor activities has not been fully elucidated. The 
induction of immunomodulating cytokines in peripheral blood mononuclear cells 
by orally administered PSK could account, in part, for the multiple 
immunomodulating activities in vivo (Kato et al., 1995). The antitumor mechanism 
of lentinan and schizophyllan has been demonstrated to involve the activation of 
the host immune system, through the regulation of cytokines in the cytokine 
network and activation of complement system QSfemoto et al., 1993). Cytokines 
are antigen-nonspecific protein or glycoprotein. They are synthesized and generally 
rapidly secreted by cells in response to a stimulus, they are not stored within the 
cells that make them. Cytokines are believed to act over a short range and to have 
very short half-lives (Benjamini and Leskowitz, 1991). In my thesis project, the 
induction of gene expression of seventeen cytokines and six cytokine receptors in 
PEC and splenocytes by PSPC administration was evaluated using reverse 
transcription-polymerase chain reaction (RT-PCR) and dot-blot hybridization to 
further understand the antitumor mechanism ofPSPC. 
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In short, the purpose of my study was to isolate a new antitumor and 
immunopotentiating component from a mushroom species available in Hong Kong. 
As purification and characterization of the active components was the first step of 
study of medicinal agents, a series of analyses of biochemical, chemical and 
physical characteristics of the active principle were designed. The research of this 
part will provide rational strategy for development and improvement of the 
biologically active substances from the mushroom. To assess the antitumor 
mechanism of active component, the immunomodulating and cytokine-potentiating 
actions of the active component were studied at the cellular and molecular levels. 
A thorough understanding of the mechanism of action will provide scientific basis 
for potential application of the substance isolated from the mushroom as a 





2. 1. Biologically active polysaccharides 
Polysaccharides, nucleic acids and proteins all carry biological 
information in their structures. Yet polysaccharides offer the highest capacity for 
carrying information because they have the greatest potential for structural variety. 
The nucleotides in nucleic acids and amino acids in proteins can interconnect in 
only one way while the monosaccharide units in oligosaccharides and 
polysaccharides can interconnect at several points to form a wide variety of 
branched or linear structures (Sharon and Lis, 1993). Two identical 
monosaccharides can bind to form 11 different disaccharides. Four different 
monosaccharides can make 35,560 unique tetrasaccharides. In addition, the 
polysaccharide also forms secondary structures, depending on the conformation of 
sugar residues, the molecular mass, and the inter- and intra-chain hydrogen-
bonding. Due to complex structure of polysaccharide, studies on polysaccharides 
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are far lagged behind the researches on nucleic acids and proteins at the molecular 
biological level. 
In the last few decades, the biological activities of polysaccharides have 
been more and more discovered. One of the promising activities of polysaccharides 
is its antitumor effects. The earliest antitumor polysaccharide investigated was 
isolated in 1943 from Serratia marcescens and became known as Shear's 
polysaccharide (Whistler et al., 1976). Shear's polysaccharide is a polysaccharide-
lipid complex. After intraperitoneal injection, Shear's polysaccharide causes 
extensive hemorrhage to Sarcoma 37 tumors in mice. As Shear's polysaccharide 
has the toxicity and other side effects, clinical tests are not performed. Moreover, 
the polysaccharides from Escherichia coli, Streptococcus pyogenes (OK-432), 
Proteus vulgaris, Acetohacter xyliniim and Salmonella typhimurium are also 
reported to have activity against solid tumors (Whistler et al., 1976). However, 
most of the antitumor polysaccharides from bacteria belong to endotoxic 
lipopolysaccharides. 
Actually the search for antitumor action of polysaccharides stems from 
dissatisfaction with cancer chemotherapy and radiotherapy. Hence, the 
enhancement or potentiation of host resistance emerges as a possible means of 
inhibiting tumor growth without harming the host. Starting from this point of view, 
extensive studies have been made on polysaccharides extracted from mushroom, 
algal, fungal and plant sources. 
Numerous antitumor polysaccharides have now been discovered from 
mushrooms, yeasts, fungi, algae, lichens and plants (Gonda et al., 1990a; Jong et 
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al., 1991; Ren et al., 1995; Sone et al., 1996). Since the earliest times mushrooms 
have been used as food and for health, and have received much attention (Chang, 
1980; Chang and Miles, 1989; Chang and Buswell, 1996). Lucas et al (1957) first 
reported the antitumor activity of extracts from the mushrooms, Boletus edulis, 
Clitopilus abortivus and so on. From then on, a lot of antitumor components from 
mushrooms were isolated and studied (Shibata et al., 1968; Miyazaki and Oikawa, 
1973; Ohmori et al., 1988a; Kishida et al., 1989). Ganoderma lucidum is one of 
the most well known medicinal fungi in Asia. Its antitumor components are widely 
studied (Saito et al, 1989; Lei and Lin, 1992; Lei and Lin, 1993; Mizuno et al, 
1995d). In the seventies and eighties, three antitumor agents of polysaccharide 
nature i.e. lentinan, schizophyllan and PSK, were isolated from Lentinus edodes, 
Schizophyllum commime and Corioliis versicolor respectively and have become 
large market items in Japan (Mizuno et al., 1995c). Lentinan and schizophyllan are 
pure p-glucans (Chihara, 1970a; Komatsu et al., 1969). PSK is a protein-bound 
polysaccharide (Tsukagoshi et al., 1984). Polysaccharide antitumor agents 
developed in Japan are shown in Table 2.1 (Mizuno et al., 1995c). 
A polysaccharide peptide (PSP) has also been isolated from Coriolus 
versicolor in China and made available commercially (Yang et al., 1992). PSP 
manufactured in China is found to be quite similar to PSK in Japan and is widely 
used in clinical treatments as an anticarcinogeneic and immunoregulatory agent. 
Furthermore, more and more mushroom species belonging to Polyporaceae, 
Tricholomataceae, Ganodermataceae, etc. are now being regarded as the next 
candidate producers of nutriceuticals and pharmaceuticals. Antitumor activity of 
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Table 2.1. Polysaccharide antitumor agents developed in Japan (Immunothera-
peutical drugs as biological response modifiers) 
Krestin Lentinan Sonifilan 
Abbreviation PSK - SPG 
Common name Krestin Lentinan Schizophyllan 




Marketed date May 1977 December 1985 April 1986 
Fungus (origin) Coriolus versicolor Lentinus edodes Schizophyllum 
commune 
(mycelium) (fruiting body) (medium product) 
Polysaccharide p-Glucan-protein P_Glucan P_Glucan 
complex 
Structure p-l,6-branching p-l,6-branching p-l,6-branching 
P-l,3:l,4-main chain (3-1,3-main chain p-l,3-main chain 
MW 100,000 500,000 450,000 
Specific rotation 一 +14-22° 0slaOH) +14-24° (water) 
Pharmaceutical 1-gsack 1-mg vial 20-mg ampoule (ml) 
preparation 
Price ¥1,000 ¥9,500 ¥9,500 
Dose route p.o. i.v. s.c. 
Cancer treated Cancer of digestive Cancer of stomach Cervical cancer 
organs, lung and breast 
References Tsukagoshi et al, 1984 Chihara et al, 1969 Komatsu et al, 1969 
Mizuno et al, 1995c Chihara et al，1970 Mizuno et al, 1995c 
Mizuno et al, 1995c 
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the extracts from various mushrooms against Sarcoma 180 are shown in Table 2.2. 
In addition, mushroom polysaccharides are now expected to be developed into 
multipurpose nutriceuticals or medicines which are not only antitumor but also 
have antiviral (useful in treating AIDS), antimicrobial, free radical scavenging and 
hepatic protective effects. Therefore, it is of great interest in the study of 
mechanism of action and improvement of polysaccharides as potential 
nutriceuticals or medicinal agents. 
2. 2. Antitumor activities of polysaccharides 
2. 2. 1. In vivo studies 
Chemotherapy and radiotherapy may directly attack tumor cells, as 
evidenced by the resulting intratumoral hemorrhage and necrosis. On the other 
hand, most of the polysaccharides from natural sources cannot be shown to exert 
any direct action on tumor cells. Their antitumor action may, therefore, be 
considered to be host-mediated. It is possible that, in some instances, these two 
types of action may be interwoven (Whistler et al., 1976). 
The preliminary antitumor activity determinations have often relied on a 
bio-assay system normally using Sarcoma 180 in mice based on an allogeneic 
tumor. The strain of mice, type of tumor, suitable dosage, and strictly planned 
timing of drug administration are essential to achieve the antitumor effect 
(Yoshikumi et al., 1975; Whistler et al., 1976; Chihara, 1992). Hundreds of 
(1^3)-p-D-glucans have been screened for their antitumor activity, and two of 
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Table 2.2. Antitumor activity of extracts from various mushrooms against Sarcoma 180 
No. Mushrooms Tumor Complete References 
inhibition (%) regression 
~[ Agaricus blazei 99.12 ^ Mizuno etal., 1990 a 
Mizuno etal., 1990 b 
2 Agrocybe cylindracea 31.3 0/6 Kiho et al., 1989 
3 Auricularia mesenterica 42.6 0/9 Chihara, 1992 
4 Amanita muscaria 41.0 - Kiho et al., 1994 
5 Amanita rubescens 72.3 0/8 Chihara, 1992 
6 Cordyceps ophioglossoides 46.0 - Ohmori et al., 1988 a 
Ohmori et al., 1988 b 
7 Coriolus hirsutus 65.0 2/10 Chihara, 1992 
8 Corioluspubesscens 59.5 0/10 Mizuno et al., 1995b 
9 Daedaleopsis tricolor 70.2 4/7 Chihara, 1992 
10 Favolus alveolarius 71.9 0/10 Mizuno etal., 1995b 
11 Fomitjpsis cytisina 44.2 3/10 Chihara, 1992 
12 Fomitopsispinicola 51.2 3/9 Mizuno etaI., 1995b 
13 Flammulina velutipes 81.1 3/10 Mizuno et al., 1995b 
14 Ganoderma applanatum 64.9 5/10 Chihara, 1992 
15 Ganoderma lucidum 81.0 2/7 Hyun et al., 1990 
Lindequist, 1995 
16 Ganoderma tsugae 77.8 2/10 Mizuno etal, 1995b 
17 Grifola frondosa 81.0 0/10 Ohno etal., 1986 
Adachi etal.，1990a 
Jong and Birmingham, 1990 
18 Grifora umbellata - 7/10 Miyazaki and Oikawa, 1973 
Miyazaki et al., 1978 
Ogawa and Kaburagi, 1982 
19 Hirschioporus fuscoviolaceus 45.5 1/10 Mizuno et al., 1995b 
20 Lepiotaprocera 64.0 1/7 Kim et al., 1989 
21 Leucofomes ulmarius 44.8 0/7 Mizuno et al., 1995b 
22 Piptoporus betulinus 49.2 0/7 Mizuno et al., 1995b 
23 Poria cocos 96.0 4/9 Chiharaetal., 1970 
24 Phellinus hartigii 67.9 1/9 Mizuno etal., 1995b 
25 Phellinus igniaarius 87.4 6/9 Mizuno etal., 1995b 
26 Phellinus linteus 96.7 - Song etal., 1995 
27 Pholiota nameko 86.5 3/10 Mizuno et al., 1995b 
28 Pleurotus ostreatus 75.3 5/10 Chihara, 1992 
29 Pleurotus spodoleucus 72.3 0/8 Mizuno et al., 1995b 
30 Trametes dickinsii 80.1 0/8 Mizuno etal., 1995b 
31 Tremella fuciformis 67.9 4/10 Ukai et al., 1972 
32 Trametes gibbosa 49.2 1/10 Chihara, 1992 
33 r. matsutake 91.8 5/9 Chihara, 1992 
34 Volvariella volvacea 100.0 6/6 Kishida et al., 1989 
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them, schizophyllan and lentinan, have been used clinically O^emoto et al., 1994). 
Schizophyllan obtained from the culture filtrates of Schizophyllum commune 
inhibits solid Sarcoma 180 when injected by intraperitoneal or intravenous route, 
but has low antitumor activity by subcutaneous route (Komatsu, 1969). After 
schizophyllan is administrated in mice by intraperitoneal or intravenous route, 
schizophyllan concentration in the serum could be measured using sandwich 
ELISA method (Hirata et al., 1994b). As time goes on, its concentration gradually 
falls (Miura et al., 1995). Schizophyllan shows some interesting effects on the 
survival rate of mice intraperitoneally implanted with Sarcoma 180 ascites tumor 
cells. Whereas pretreatment with schizophyllan in the mice has no effect, combined 
pre- and post-treatment, and post-treatment, result in the increase of survival of 
57% and 43% of the treated mice respectively. However, schizophyllan has no 
effect on the survival of mice intraperitoneally implanted with Sarcoma 37，Ehrlich 
carcinoma, or Yoshida sarcoma ascites tumors (Whistler et al., 1976). Lentinan 
extracted from the fruiting body of Lentmus edodes exerts prominent antitumor 
activity against allogeneic, syngeneic, and autochthonous tumors in mice (Zakany 
et al., 1980; Suga et al., 1984; Ochiai et al., 1992). The antitumor activity of 
lentinan is originally confirmed by using Sarcoma 180 transplanted in Swiss albino 
mice (Chihara et al., 1969). The antitumor activity of lentinan largely depends on 
the strains of mouse to which they are administered. A/J, DBAy'2 and CD-1 mice 
are strongly responsive and complete tumor regression can be achieved in these 
strains, whereas it is somewhat less effective in BALB/c and CBAAF mice and 
ineffective in C3H/He and C57BL/6 mice (Chihara, 1992). When the DBAy'2 and 
13 
BALB/c mice are used, the intraperitoneal injection oflentinan inhibits the growth 
of methylcholanthrene-induced fibrosarcoma. Lentinan is also effective against 
various semisyngeneic tumors, such as P815 mastocytoma, L-5178Y lymphoma, 
virus-induced MM-46, and MM-102 carcinoma (Chihara，1992). -In Japan, PSK 
from the cultured mycelia of Corioliis versicolor exhibits a marked antitumor 
effect against allogeneic tumors such as Sarcoma 180 and Ehrlich carcinoma of 
experimental animals not only by intraperitoneal administration but also orally 
(Tsukagoshi, 1984). The fate ofPSK in the digestive tract and the serum after oral 
administration is observed by ^^C-labeled and ^^S-labeled PSK (Tsukagoshi, 
1984). The blood radioactivity after oral administration of "C-labeled or ^^S-
labeled PSK to the mice reaches maximal peak in 30-60 min and decreases 
thereafter. It was found that PSK was only partially decomposed to small 
molecules in the digestive tract. PSK is mainly absorbed in its large molecular form 
and exist in this state in the blood after administration of either ^^C-labeled or ^^S-
labeled PSK. This suggests that ^^C-labeled or ^^S-labeled PSK is absorbed rapidly 
from the intestines and that the absorbed "C-labded or ^^S-labeled PSK is 
transferred into the organs and then eliminated from the body. When PSK is 
administered intraperitoneally at the time ofsubcutaneous inoculation of syngeneic 
tumors such as methylcholanthrene-induced fibrosarcoma in C57BL/6 mice, a 
significant growth inhibition of tumor is observed (Ohno et al, 1975). It is of 
interest that PSK shows some effects against semisyngeneic tumors such as 
adenocarcinoma 755 (Tsukagoshi, 1974 a), mammary tumor S-MT (Ehrke et al, 
1983), P388 leukemia and L1210 leukemia (Tsukagoshi, 1974a) under in vivo 
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experimental conditions. As for rat tumors, PSK is effective against ascites 
hepatoma AH-13 by administered orally (Tsukagoshi, 1974b). In China, PSP 
isolated from the cultured mycelia of Coriolus versicolor also exhibits high 
antitumor activity (Yang et al., 1992). Similarly, polysaccharides from other 
natural resources, for instance, curdlan from the bacterium Alcligems faecalis 
(Ohya et al., 1994), funoran from the alga Gloiopeltis tenax (Ren et al., 1995) and 
acid polysaccharide from the plant Pimis parviflora (Sakagami et al., 1987) are 
found to have significant antitumor activity in vivo. 
Some researchers use the conjugates of mitomycin C with antitumor 
polysaccharides such as schizophyllan (Usui et al., 1994) and PSK (Fujii et al., 
1989) to maintain the effect of the cancer chemotherapeutic agents and to reduce 
toxic side effects. The mechanism of the conjugates of antitumor polysaccharides 
with other chemotherapeutic agents employed, including cyclophosphamide, 
nimustine and 5-fluorouracil, has been widely studied (Mizushima et al., 1982; 
Ebina and Murata, 1992). This study provides possible for clinical applications of 
polysaccharides. 
2. 2. 2. In vitro studies 
Various glucans such as schizophyllan and lentinan show no direct growth- -
inhibitory effects on the tumor cell lines in vitro (Sakagami et al., 1990; Sakagami 
et al., 1991a; Aoyagi et al., 1994). However, the indirect cytotoxicity of lentinan 
is observed in vi1ro. Lentinan enhances the antitumor cytotoxic activity of 
peritoneal macrophages against human melanoma target cells in vitro (Ladanyi et 
15 
al., 1993). The activity of lymphokine-activated killer cells stimulated by IL-2 and 
lentinan against autologous tumor cells and K562 human erythroleukemia cells is 
greater than that stimulated by IL-2 alone in vitro. The optimal concentration of 
lentinan for the generation of killer cells ranges from 25-500 ng/ml, a level which 
could be achieved in vivo by the administration of clinical doses (2.0 mgy^ kg) ofthis 
agent (Sasaki and Takasuka, 1976; Tani et al., 1993). Unlike most glucans, PSK 
(protein-bound polysaccharide) has both direct and indirect cytotoxic effects on 
tumor cell lines in vitro. When L1210 leukemia cells or P815 mastocytoma cells 
are mixed with PSK in vitro, and inoculated subcutaneously in BDFi mice, tumor 
suppression takes place (Tsukagoshi et al., 1984). It is reported that PSK enhances 
the cytotoxic activity of peripheral blood lymphocytes (PBL) against T24 human 
urinary bladder tumor cell line after PBL are incubated with PSK at concentration 
of 10-100 pig/ml in vitro (Mizutani and Yoshida, 1991; Mizutani et al., 1992). The 
level ofDNA synthesis in PBL increases in the presence ofPSK, and the maximum 
increase is obtained when PBL are cultured with PSK at 100 pig/ml for 5 days O^io 
et al., 1991). When L-929 cells are treated with TNF-a in the presence of 30 
HgAnl ofPSK in vitro, the cytotoxic action of TNF-a is enhanced (Kim et al., 
1990; Sakagami et al., 1991a). Moreover, PSK inhibits growth and DNA synthesis 
in vitro in various cell lines such as L1210 leukemia, P388 leukemia (Yanagawa et 
al., 1983)，Ehrlich carcinoma, Yoshida sarcoma, AH-13 (Tsukagoshi et al, 1984), 
human hepatoma C-HC-20 (Sano et al., 1981), human choriocarcinoma GCH-1 
and GCH-2 (Kanazawa et al., 1983), and human breast cancer cell MCF-7 (Aoyagi 
et al., 1994). These results show that antitumor effects ofPSK may be, in part, due 
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to its direct cytotoxicity. Similarly, PSP has a wide range of antitumor activities in 
vitro, inhibiting Ehrlich ascites tumor, leukemia P388, Sarcoma 180 and four types 
ofhuman cancer cell lines including human gastric cancer cells, human lung cancer 
cells, mononuclear leukemia cells and human skin histiocytic lymphoma cells 
(Yang et al., 1992). In addition, a small polypeptide isolated from the crude 
extraction ofPSP has higher cytotoxic effect than that ofPSP and PSK on HL-60, 
LS174-T, SMMU-7721 and SCG-7901 cell lines (Yang and Chen et al., 1992). 
PSK, PSP and most of glucans such as lentinan and schizophyllan are different in 
antitumor activity in vitro. It is suggested that PSK and PSP may have some 
unique structural features, possibly generated from the involvement of protein 
portions and/or unique structural configurations including sugar to sugar linkages 
(Sakagami et al., 1991a). 
2. 3. Antitumor mechanisms of polysaccharides 
In the past few decades, numerous polysaccharides have been identified to 
have antitumor activities (Whistler et al., 1976; Jong et al., 1991; Chihara, 1992; 
Mizuno et al., 1995b). However, the complete answers to antitumor mechanism of 
polysaccharides are not yet available. At present, it is generally believed that 
antitumor polysaccharides mainly restore or enhance various immune responses in 
vivo though their direct cytotoxic effects are also observed in vitro. 
Tumor-associated immunosuppression in animal models has been the 
subject of much discussion. The lymphocytes from tumor-bearing host are 
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hyporesponsive to various mitogenic and antigenic stimuli. This immunodepression 
might be attributed to the presence of a variety of soluble factors in the circulation 
oftumor-bearing host (Shibata et al., 1983). In BALB/c mice, when plasmacytoma 
(PC) is grown as an ascitic tumors or subcutaneous tumors, PC eells produce a 
soluble factor (transforming growth factor beta, TGF-P) that prevents spleen cells 
ofhost from proliferating in response to mitogens, and arrest them late in the G1 
phase ofthe cell cycle (Berman and Pazner, 1987). TGF-p is a 25-kDa disulfide-
linked peptide homodimer synthesized and secreted by a variety of cells, such as 
the activated macrophages, T cells and so on. It has the interesting property of … 
being a bifunctional modulator of cell growth and differentiation, it can either 
stimulate or inhibit the proliferation of a variety of cell types (Kehrl et al., 1986a). 
The ascites fluid from the PC-bearing mice contains large quantities ofTGF-p. The 
supernatants of cultured spleen cells from the PC-bearing mice contain up to 
eightfold more TGF-P than is found with the normal spleen cells. In the PC-
bearing mice, TGF-p leads to the abnormal pattern of expression of several 
activation and recognition molecules on B lymphocytes. In vitro, TGF-P induces 
normal B lymphocytes to express the same abnormal pattern as seen in the PC-
bearing mice (Berg and Lynch, 1991). TGF-p also inhibits the proliferation of � 
human T and B lymphocytes (Kehrl et al., 1986a; Kehrl et al., 1986b; Micallef et 
al., 1994)，blocks the transition of pre-B to mature immunocompetent B cells. It is 
reported that the addition of exogenous TGF-p to the cultures of T lymphocytes 
inhibits IL-2 dependent T cell proliferation, and that activated T cells themselves 
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synthesize and secrete TGF-p. Therefore, it is suggested that TGF-P is related to 
tumor-associated immunosuppression. 
Another soluble factor, immunosuppressive acidic protein (IAP), is also 
discovered in the tumor-bearing host (Tamura et al., 1981). IAP is a oci-acid 
glycoprotein produced by liver cells, neutrophils and activated macrophages. It has 
a molecular mass of 50 kDa. IAP in serum determined with a single radial 
immunodiffusion method is gradually increased after intradermal inoculation of 
Meth-A tumor in BALB/c mice (Ebina et al., 1994). The sera and ascitic fluids 
obtained from cancer patients contain dramatically increase amounts of IAP. An 
intravenous administration of IAP (5 mg/mouse) into the normal mice not only 
induces the same unresponsiveness of spleen cells to Con A shown by the tumor-
bearing mice but also induces suppressor cells in the spleens of these mice. The � 
association between elevated levels of IAP in the sera of the tumor-bearing mice 
and the appearance of suppressor cells suggests the possible role of this potent 
biological immunosuppressive substance in reducing the immunological 
surveillance mechanism of the host (Shibata et al., 1983). Therefore, tumor-
associated immunosuppression is thought to provide the means by which tumor 
cells escape immunological surveillance to proliferate and eventually kill the host. 
These studies might provide an evidence that the restoration and augmentation of 
immune level are quite important for antitumor activity in the tumor-bearing hosts. 
Although it has been reported that antitumor polysaccharides enhance and 
restore the immune levels of hosts (Gonda et al., 1990b; Tanaka et al., 1992; Lin, 
19 
1993), the effects of different polysaccharides, such as lentinan, schizophyllan, 
PSK and PSP, on immune systems can not be generalized. 
Lentinan can restore and/or augment responsiveness of host cells, but has 
no direct cytotoxicity against tumors (Table 2.3). The antitumor effect of lentinan 
is lost in the neonatal thymectomized mice, and decreased considerably by 
administration of antilymphocyte serum (Maeda and Chihara, 1971). The results 
suggest that the antitumor action of lentinan requires an intact T cell compartment 
and that the activity is mediated through thymus-dependent immune mechanism. 
Interestingly, the antitumor activity of lentinan is also inhibited by pretreatment 
with anti-macrophage agents. Thus, lentinan is also defined as a T cell-oriented 
adjuvant in which macrophages play a part (Maeda et al., 1974). In addition, the 
induction of a marked increase in the amounts of CSF, IL-1 and IL-3 by lentinan 
results in maturation, differentiation and proliferation of the immunocompetent 
cells for host-defense mechanism (Chihara, 1992). Similarly, lentinan is able to 
restore the suppressed activity of helper T cells in the tumor-bearing host to their — 
normal state, leading to complete restoration of humoral immune responses (Heba 
et al., 1976). Moreover, it is reported that the delayed-type hypersensitivity 
responses induced by lentinan are consistent with the antitumor effects of lentinan 
in the tumor-bearing mice (Suzuki et al, 1994). The research suggests that 
delayed-type hypersensitivity responses at the tumor sites induced by lentinan and 
the subsequent infiltration of immune effector cells, such as natural killer cells and 
cytotoxic T lymphocytes, into the tumor burden appear to be important in the 
antitumor action of lentinan. Recent observation shows that lentinan inhibits 
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Table 2.3. Immunological activities of Lentinan 
Immunological types Immunological effects References 
T- cell participation 
Helper T cell in vitro No observed effect Suzuki et al, 1994 
Helper T cell in vivo Activation or restoration Chihara, 1992 
Cytotoxic T cell in vitro Augmentation ofIL-2 response Chihara, 1992 
Cytotoxic T cell in vivo No induction Suzuki et al, 1994 
Migration inhibitory factor-
producing T cells Activation Chihara, 1992 
T-cell-derived CSF Increased production Chihara, 1992 
IL-3 Increased production Chihara, 1992 
IL-2 Noincreasedproduction Chihara, 1992 
Natural killer-cell participation 
NK cell in vitro No effect Chihara, 1992 
NK cell in vivo Activation in C3H/He, but not 
BALB/c and BDF1 mice Suzuki et al, 1994 
Macrophage participation 
Mq): phagocytosis in vitro No effect Maeda et al, 1988 
Mq): phagocytosis in vivo Weak effect Maeda et al, 1988 
Mq) : cytotoxicity in vitro Activation Ladanyi et al, 1993 
Mq): cytotoxicity in vivo Activation Ladanyi et al, 1993 
Mq) : suppression in vivo Decreased prostaglandin E 
release from macrophages Chihara, 1992 
CSF lncreasedproduction Chihara, 1992 
Monocyte participation 
IL-1 Increased production Maeda et al, 1988 
IL-6 Increased production Sakamaki et al, 
1993 
Cellular reactions 
Delayed hypersensitivity in Stimulation or restoration Suzuki et al, 1994 
vivo 
Local cellular reaction Increase around tumor Suzuki et al, 1994 
Neutrophil invasion Increase around tumor Chihara, 1992 
Granuloma formation Increase around shistosoma Chihara, 1992 
Complementary participation 
Alternative pathway Activation Maedaetal, 1988 
C3 splitting activity Activation Chihara, 1992 
C3 absolute valus Increased production Chihara, 1992 
Total complement value Increased production Chihara, 1992 
Classical pathway Activation Chihara, 1992 
Antibody formation 
Antibody for SRBC Increased production with T cells Chihara, 1992 
Antibody-dependent 
macrophage cytotoxicity Augmentation Chihara，1992 
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hepatic metastasis in adenocarcinoma 26-bearing mice by activated KupfFer cells 
(Taki et al., 1995). Therefore, it remains to be clarified which immunomodulating 
effects induced by lentinan is a critical action for tumor rejection. 
PSK has no substantial effect on immune response of the host under normal 
conditions (Table 2.4). It has the ability to restore immune responses to the normal 
levels after the host has been depressed by tumor-burden or anticancer 
chemotherapeutic agents (Mizushima et al., 1982; Tsukagoshi et al., 1984). In ICR 
mice, antibody production against trinitrophenyl that depressed in Sarcoma 180-
bearing mice can be restored by PSK. In AKR mice, on the other hand, antibody 
production is not depressed in Sarcoma 180-bearing mice and is not augmented by 
PSK (Yoshikumi et al., 1975). PSK augments the cytotoxic activity of peripheral 
blood lymphocytes (PBL) in vivo and in vitro. It may accelerate interaction ofPBL 
with tumor cells such as T24 human urinary bladder tumors when both effector 
cells and target cells are exposed to PSK simultaneously. Moreover, after the 
intratumoral administration of PSK, it may come into close contact with tumor 
cells, whereupon local inflammatory responses occur and result in the non-specific 
killing oftumor cells (Ebina and Murata, 1992). Therefore, local administration of 
PSK is more efficient than systemic one (Mizutani and Yoshida, 1991). It is 
reported that PSK induces gene expression of some cytokines such as TNF-a, H.-
1，IL-8 and IL-6, in vivo or in vitro (Hirose et al., 1990; Kato et al., 1995). These 
cytokines produced by monocyte, macrophage and various other cell types 
mediate multiple biological effects by direct stimulation of cytotoxic T cells against 
tumors, enhancement of antibody production by B lymphocytes and induction of 
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Table 2.4. Immunological activities ofPSK 
Immunological types Immmunological effects References 
In vivo (Tumor-bearing host) 
Cytotoxic T cell Augmentation Tsukagoshi et al, 1984 
Natural killer QSfK) cell Activation Morinaga et al, 1994 
Macrophage phagocytosis Activation Tsukagoshi et al, 1984 
Macrophage cytotoxicity Activation Tsukagoshi et al, 1984 
Suppressor T cell Decrease Tsukagoshi et al, 1984 
Delayed hypersensitivity Stimulation or restoration Fujii et al，1989 
C3 complement Increased production Tsukagoshi et al, 1984 
Antibody for SRBC Increased production Fujii et al, 1989 
Neutrophil invasion Increase around tumor Tsukagoshi et al, 1984 
Macrophage-derived CSF Increased production Sakagami et al, 1991a 
Spleen-derived IL-2 Increased production Tsukagoshi et al, 1984 
Monocyte-derived 
IFN Increased production Tsukagoshi et al, 1984 
TNF-a Increased production or no effect Kato et al, 1995 
IL-8 Increased production or no effect Kato et al, 1995 
In vitro — 
Macrophage phagocytosis Activation Sakagami et al, 1991a 
Macrophage cytotoxicity Activation Nio et al, 1991 
Monocytes-derived 
IL-ip Activation Morinaga et al, 1994 
IL-la Increased production Hirose et al, 1990 
TNF-a Increased production Hirose et al, 1990 
IL-6 Increased production Hirose et al, 1990 
IL-8 Increased production Hirose et al，1990 
IL-2 No effect Hirose et al, 1990 
Spleen-derived IFN Increased production Tsukagoshi et al, 1984 
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JL-2 receptor expression on T lymphocyte. The induction of TNF-a by PSK 
would contribute, in part, to potent tumoricidal effects of this agent since the 
administration of neutralizing antibody against TNF-a significantly attenuates the 
antitumor activity o fPSK in the murine model (Kato et al., 1995). The recent 
study also indicates that PSK exerts tumoricidal activity by inducing T cells that 
recognize PSK as an antigen and kill tumor cells in an antigen-specific manner 
(Ozakai et al., 1995). Similarly, polysaccharide peptide (PSP) is able to suppress 
the growth of human cancer cell lines and reverse tumor-induced 
immunodeficiencies in mice by increasing IgG and C3 complement levels (Yang et 
al., 1992). The antitumor action ofPSK and PSP appears to be due to both host-
mediated immunomodulation and cytotoxicity. 
Lentinan, PSK and PSP are different in their chemical composition and 
biological activity. It remains to be elucidated whether the differences of their 
biological activity are due to the presence of protein units as complexes. On the 
other hand, schizophyllan is similar to lentinan in the composition and biological 
activity (Whistler et al., 1976; Jong et al., 1991). The antitumor effect of — 
schizophyllan is diminished in the mice neonatally thymectomized and treated with 
antithymus globulin. Schizophyllan restores and enhances cellular immunity in the 
tumor-bearing host by functioning as a T cell adjuvant and macrophage activator. 
The antitumor activity of schizophyllan is mediated by the cooperation of T-
lymphocytes and macrophages since impairment of either of these cells decreased 
its antitumor activity (Suzuki et al., 1982; Isamu et al., 1984). In recent years, the 
induction of gene expression of cytokines by schizophyllan has been studied in 
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vitro and in vivo O^emoto et al., 1993; Nemoto et al., 1994; Okazaki et al.，1995). 
After schizophyllan is administered intraperitoneally in ICR mice, the kinetics of 
gene expression of cytokine are different in peritoneal exudate cells, splenocytes 
and liver cells. It is generally accepted that protein synthesis and gene expression 
of cytokines are regulated separately. Therefore, the antitumor activity of 
schizophyllan is mainly due to host-mediated immune responses C^emoto et al., 
1994; Okazaki et al.，1995). Another (1^3)-p-D-glucan, grifolan from Grifola 
frondosa, is similar to schizophyllan in the primary structure (Adachi et al., 
1990b). Enhancement of the mRNA levels of IL-6, IL-1 and TNF-a of 
macrophages by grifolan treatment is detected by RT-PCR in vitro, showing that 
grifolan is a novel macrophage activator which augments cytokine production 
(Adachi et al., 1994). 
2. 4. Structure and antitumor activities of polysaccharides 
Polysaccharides having antitumor action differ greatly in their chemical 
composition and configuration and physical properties. Antitumor activity is 
exhibited in a wide range of glycans extending from homopolymers to highly 
complex heteropolymers. Although it is difficult to correlate the structure and 一 
antitumor activity of complex polysaccharides, some possible relationships can be 
inferred. It has been reported that most of the antitumor polysaccharides such as 
lentinan, schizophyllan and so on, show the same basic P_glucan structure. 
However, obvious variations of antitumor polysaccharides are also noted. There 
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are antitumor polysaccharides with other chemical structures, such as hetero-p-
glucan (Mizuno et al., 1995b), heteroglycan (Zhuang and Mizuno, 1995), P_ 
glucan-protein (Kawagishi et al., 1990a)，a-manno-p-glucan (Mizuno et al.， 
1995b), a-glucan (Tanigami et al., 1991) and a-glucan-protein (Mizuno et al., 
1995b). PSK and PSP are a complex P-glucan-protein. Therefore, it is difficult to 
identify which polysaccharide structure is essential for antitumor action. It has 
been shown that molecular mass, the degrees of branching, conformation and 
chemical modification of antitumor polysaccharides affect their antitumor and 
immunomodulating activities (Chihara et al., 1970b; Kiho et al., 1989; Adachi et 
al., 1990b; Ohno et al., 1995). 
2. 4. 1. The effect of molecular mass 
When PSK is separated into four fractions with different molecular masses 
(Fl： <50 kDa; F2: 50-100 kDa; F3: 100-200 kDa; F4: > 200 kDa) by successive 
filtration, the highest molecular mass fraction (>200 kDa) has the most potent 
immunomodulating activity (Kim et al., 1990; Sakagami et al., 1990). A (l~>3)-p-
glucan, LELFD is prepared from the cultured mycelium of Grifola frondosa 
(Adachi et al., 1990b). Changes of biological activities of LELFD are manifested 
with various molecular masses obtained by heat treatment for varying times at 
150°C. The highest molecular mass fraction (800 kDa) always exhibits most strong 
antitumor and immunomodulating activities (Adachi et al., 1990a; Adachi et al., 
1990b). These investigations have raised the possibility that antitumor 
polysaccharides may not always be multiple enhancers ofhost defense systems, and 
26 
that high molecular mass is required for extensive enhancement of immunological 
and antitumor activities. On the contrary, the low molecular masses oflentinan and 
schizophyllan exhibit the same antitumor activity against Sarcoma 180 as the 
higher ones (Sasaki and Takasuka, 1976; Tabata et al., 1981; Ogawa and 
Kaburagi, 1982). The discrepancy remains to be studied. 
2. 4. 2. The impact ofbranching configuration 
In general, p-glucans are active antitumor agents if they are mainly linear, 
not excessively long branches. For example, pachyman, a branched p-glucans 
obtained from Poria cocos is inactive, whereas pachymaran, obtained by 
debranching pachyman using periodate oxidation and mild hydrolysis, exhibits 
pronounced antitumor activity (Chihara et al., 1970b). Lentinan (2/5) is a P-l,3-D-
glucan with two branches for every five D-glucopyranosyl residues (Chihara, 
1992). Schizophyllan (1/3) is also a P-l,3-D-glucan with one branch for every 
three D-glucopyranosyl residues (Tabata et al., 1981). The moiety of 
polysaccharide ofPSK (1/5) is a P-l,3; 1,4 -D-glucan ofone branch for every five 
D-glucopyranosyl residues (Tsukagoshi et al., 1984). Although the degree of their 
branches is different, their antitumor activities are not obviously different. 
However, the debranched lentinan preparations are more effective against Sarcoma 
180 than the native lentinan at a dose of 2.0 mg/kg for five days in mice (Sasaki 
and Takasuka, 1976). In addition, a highly branched P-l,3-D-glucan (2/3, two 
branches for every three D-glucopyranosyl residues), called OL-2, extracted from 
Omphalia lapidescem also shows antitumor activity on the solid form of Sarcoma 
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180 when administered intralesionally, and increases the life span of mice treated 
with ascites form ofSarcoma 180 and MH 134 hepatoma (Saito et al., 1992; Ohno 
et al., 1992). At the molecular level, it is found that the cytokine expression 
patterns between schizophyllan (1/3) and OL-2 (2/3) of antitumor polysaccharides 
are also different OSfemoto et al., 1993; Nemoto et al., 1994). The OL-2 
administered mice strongly express IL-la, IL-ip and IL-lra genes in peritoneal 
exudate cells, while schizophyllan only induces the expression of IL-la. In the 
genes related to haematopoiesis, OL-2 induces the expression of G-CSF and GM-
CSF, but schizophyllan induces the expression of EL-3 O^emoto et al., 1993; — 
Nemoto et al., 1994). Therefore, the relationships between antitumor activity and 
the branch ratios of P-glucan are quite complicated. 
2. 4. 3. The relationship between antitumor activity and conformation 
Conformations of antitumor polysaccharides include single helix, triple 
helix and random coiled conformers. A triple helix conformer is usually more 
stable than the single helix conformer, since a certain part of the single helix 
conformer is gradually changed to the triple one. Lentinan, schizophyllan and PSK 
are all triple helix structure (Tsukagoshi et al., 1984; Chihara, 1992; Ohno et al., 
1995). Pachyman belonging to single helix conformer is inactive. The alkaline-
treated schizophyllan (schizophyllan-OH) is also a single helix. Schizophyllan-OH 
also shows a slightly reduced ability to inhibit tumor growth compared to the 
native schizophyllan. Therefore, the antitumor activity of polysaccharide 
apparently depends on the helical conformation (Ohno et al., 1995). The 
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relationship of conformation and antitumor activity of polysaccharides suggests 
that the existence of biological systems within the host body recognizes the 
configurational structure of polysaccharide. 
2. 4. 4. Improvement of antitumor activity by chemical modification 
To improve the biological activity of antitumor polysaccharides by chemical 
modification, carboxymethylated, hydroxylated, formylmethylated, aminethylated 
and sulfated products have been designed. The linear a-l,3-D-glucans from 
Amanita muscaria and Agrocyhe cylindracea have little antitumor activity (Kiho 
et al., 1989; Kiho et al., 1994). However, the carboxymethylated linear a-l,3-D-
glucan shows high potent antitumor activity against Sarcoma 180 and 
immunomodulating activity in mice (Yoshida et al., 1996). The nitric oxide and … 
TNF-a concentrations from peritoneal exudate cells induced by hydroxylated 
schizophyllan administration are higher than those by native schizophyllan in vivo 
(Ohno et al., 1995). The antitumor activity of the formylmethylated and 
aminoethylated derivatives of schizophyllan against Sarcoma 180 solid tumor in 
mice is increased more effectively than that of the native schizophyllan (Usui et al., 
1995). It is noteworthy that the sulfated lentinan and schizophyllan products 
exhibit strong anti-human immunodeficiency virus activity though with reduced 
antitumor effect (Yoshida et al., 1988; Ito et al., 1990; Hirata et al., 1994a). These 
researches show that the chemical modification of polysaccharides might be an 
effective model ofimproving biological activity of polysaccharides. 
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Nevertheless, it is clear that although the relationships between the 
structure and antitumor activity of polysaccharides have been extensively studied, a 
lot ofdiscrepant results remain to be clarified and elucidated. 
2.5. Other biological activities 
2. 5. 1. Antiviral activity 
Although some chemical drugs have antiviral activity, their side effects to 
the normal cells are extremely serious ui vivo. Thus, it is urgently necessary to 
develop effective agents which have antiviral activity, with no severe side effects. 
Antiviral activities of lentinan against adenovirus type 12, Abelson virus 
and VSV-encephalitis virus are observed (Chihara, 1992). PSK can resist 
ectromelia virus and cytomegalovirus infections (Tsukagoshi et al., 1984) and 
inhibit cell-free infection of human immunodeficiency virus (HIV) (Tochikura et 
al., 1989). Lentinan itself has no ability to block HIV infection, but concomitant — 
treatment with 3'-azido-3'-deoxythymidine (AZT) suppresses the surface 
expression ofHIV antigens more than does AZT alone. It is possible that lentinan 
augments AZT efficacy on inhibiting HIV replication through stimulation of 
various cell lines to produce a variety of factors that interfere with HIV replication 
(Tochikura et al., 1987). AZT generally has toxic side effects in AIDS patients. 
Thus, the modification of antitumor polysaccharides especially attracts attention. 
Sulfated lentinan and schizophyllan have strong anti-HIV effects though their 
antitumor activity are decreased or abolished (Yoshida et al., 1988; Ito et al., 
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1990; Hirata et al., 1994a). At present, it is not clear why sulfated lentinan and 
schizophyllan result in the generation of anti-HIV activities. Moreover, it is 
reported that the degraded form of schizophyllan (Muenzberg et al., 1995) and the 
extracts from Ganoderma lncidum (Kim et al., 1994; Bang, 1995) also have anti-
HIV activity. 
2. 5. 2. Antimicrobial activity 
Antimicrobial drugs have been employed for prophylactic and therapeutic 
purposes. However, recent occurrence of drug-resistant strains has made treatment 
difficult. Thus, the antimicrobial activity of various antitumor polysaccharides is 
evaluated. Schizophyllan has the ability to enhance protection against 
Streptococcus sp. infection (Matsuyama et al., 1992). Lentinan is therapeutically 
effective against Mycobacterium tuberculosis and Listeria monocytogenes 
(Chihara, 1992). PSK induces potent antimicrobial activity against Escherichia 
coli, Listeria moiiocytogems and Candida (Tsukagoshi et al., 1984; Sakagami et 
al., 1991a). The acidic polysaccharides from the plant Pimis parviflora exhibits 
antimicrobial activity against Escherichia coli (Harada et al., 1988). It is 
suggested that the phagocyte activation and NO production of macrophages — 
contribute to the antimicrobial activity of polysaccharides (Tsukagoshi et al., 1984; 
Ohno et al., 1996). 
31 
2. 5. 3. Free radical scavenging activity 
Reactive oxygen species produced by sunlight, ultraviolet, ionizing radiation, 
chemical reactions and metabolic processes, have a wide variety of pathological 
effects, such as DNA damage, carcinogenesis and cellular degeneration related to 
aging (Zheng et al., 1988). The extracts of Ganoderma lucidiim improve 
endurance and antifatigue ability of the host under the condition oflack of oxygen. 
It is known that the extracts of Ganoderma htcidum can strongly remove the 
hyperoxide free radical which is the main factor in aging of the body (Yang and 
Wang, 1994). Superoxide radical could be quenched rapidly in the presence of 
PSK in the cell-free system consisting of hypoxanthine-xanthine oxidase, whereas 
natural glucans, such as schizophyllan, did not (Sakagami et al., 1991a; Sakagami 
et al., 1992). PSP has scavenging effects on superoxide and hydroxyl radicals. It is 
also a good antioxidant (Hu et al., 1992). 
2. 5. 4. Hepatic protective effect 
Some epidemiological investigations show that the number of people who 
suffer from various liver disorders has increased. This trend will have obvious 
medical and social implications in the near future. In the past several years, with 
regard to the development of the liver protective agents, many attempts have 
focused on natural products (Chiu et al., 1988; Chiu et al., 1989). Polysaccharide 
peptide from Coriolus versicolor is effective in protecting the liver from 一 
hepatotoxins in rats (Yeung et al., 1994). Tremella polysaccharides can promote 
the synthesis of protein and RNA in mouse liver cells (Lin, 1993). Therefore, the 
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Chapter 3 
Isolation and Characterization of a Polysaccharide-Protein 
Complex (PSPC) from Tricholoma lohayense 
3. 1. Introduction 
Antitumor polysaccharides are present in a variety of natural sources, 
including mushrooms, yeasts, algae, bacteria and plants. They exists in various 
forms, such as polysaccharide, polysaccharide-protein and polysaccharide-lipid. In 
addition to the compositional variations, their structures are also varied, depending 
on molecular mass, degrees of branching and solubility to water. Furthermore, in 
• * 
the process of extraction of antitumor polysaccharides, it is found that different 
solvents extract different antitumor components. However, although the antitumor 
components from natural sources are different, their antitumor actions are all 
attributed, at least in part, to host-mediated immunity. Three immunomodulators, 
lentinan (Chihara et al., 1970a), schizophyllan (Komatsu et al., 1969) and PSK 
(Tsukagoshi et al., 1984) have been used clinically in Japan. PSK was obtained 
from Coriolus versicolor by hot water extraction of the mycelia followed by 
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saturated ammonium sulfate precipitation (Tsukagoshi et al., 1984). The desalting 
time of this method is quite long by dialysis against water. PSK purification was 
based on different molecular masses or based on different solubilities against 
various buffers (Sakagami et al., 1990). Lentinan was isolated from the water-
soluble extracts of the fruiting bodies from Lentums edodes by fractional 
precipitation with ethanol. It was purified using extraction in graded acetic acid 
(Chihara et al., 1970a). The process of this purification is complicated. 
Schizophyllan was produced from the culture filtrates of Schizophyllum commune 
by fractional precipitation with methanol (Kikumoto et al., 1970). Methanol is not 
quite safe. Therefore, in the present study, the fractions from T. lobayense were 
obtained by ethanol precipitation. DEAE-cellulose column was used for 
purification purpose. 
Lentinan and schizophyllan are pure glucans. Lentinan shows high 
antitumor activity when injected by the intravenous route, but it is hardly soluble in 
water (0.1%) without autoclaving (Chihara, 1992). Therefore, lentinan is not a 
final form of drug product. Although schizophyllan has a variety of administration 
routes including intraperitoneal, intravenous, subcutaneous and intramuscular 
routes, its preparation and administration for therapeutic purpose are also difficult 
due to the high viscosity ofits aqueous solution (Tabata et al., 1981). PSK shows 
antitumor activity by both oral and intraperitoneal administration. It has high 
solubility to water. However, its active site is still poorly understood. Hence, it is 
desirable to look for and study any new antitumor principle from natural sources. 
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3. 2. Materials and Methods 
3. 2. 1. Strain 
Tricholoma lohayense Heim used in this study was collected from ground 
around the plant Delonix regia on the campus of the Chinese University ofHong 
Kong, Hong Kong (Fig. 3.1). Fruiting bodies (basidocarp) are both large and 
white. Cap (pileus) diameter is about 3-15 cm. It may be seen that gills (lamellae) 
are not all of the same length, they bend inwards and converge from the 
circumference towards the stalk (stipe). The size of ovoid or elliptic spores is 3.5-
5 X 5-7.5 ixm, and the spore print is white. The length of stalk is about 7-16 cm, 
and its basal inflation is obvious (Chang and Mao, 1995). Production of the 
fruiting bodies of T. lobayeme by cultivation methods and conditions in our 
laboratory was not successfully. 
3. 2. 2. Culture conditions 
Antitumor activity of mushroom polysaccharide complexes may be related : 
to the culture conditions of the mushroom. It was reported that Schizophyllum j 
\-. 
commune that produced schizophyllan with antitumor activity was cultured in the 
. f 
culture medium of glucose as carbon source and glycine, aspartic acid and Na 
glutamate as nitrogen sources (Komatus et al., 1970). In our laboratory, the 
mycelia of T. lobayeme were successfully cultured after screening and selection for 
a culture medium with optimal condition (Fig. 3.2). The result showed that glucose 
was a suitable carbon source and peptone was a suitable nitrogen source for 
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Fig. 3.1. Tricholoma lohayense Heim 
The strain was collected from ground around the plant Delouix regia 
on the campus ofthe Chinese University ofHong Kong’ Hong Kong. 
(Photos by courtesy ofProf. S.T. Chang, Department ofBiology, the 
Chinese University of Hong Kong, Hong Kong; Prof. X.L. Mao, 
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Fig. 3.2. Cultured mycelia and culture filtrates ofT. lobayense 
a. The strain was cultured in potato dextrose agar plates 
for seven days at 28°C. 
b. The strain was cultured in nutrient broth at 28°C on a 
rotary shaker for six days. 
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T. lohayense that produces the active ingredient with antitumor activity in culture 
filtrates. 
Strains stored at room temperature were recovered on potato dextrose 
agar plates for 7 days at 28°C. Then, the strains were subcultured into nutrient 
broth containing (gy'l): glucose 20, peptone 1，yeast extract 0.5, malt extract 0.5, 
KH2PO4 0.46’ K2HPO4 1, MgSO4 • 7H2O 0.5 and VBi, 0.02. pH was 6.0. They 
were cultured at 28°C on a rotary shaker at 180 rev/ min for 6 days. In this 
experiment, the composition of the culture medium and cultured time were fixed. 
3. 2. 3. Extraction ofT. lohayense (Chihara et al., 1970a) 
The culture broth (10 1) of T. lobayense was filtered. The culture filtrates 
were concentrated 5-fold using rotary evaporator, and then 3 volumes of 100% 
ethanol were added to the concentrate. To complete the precipitation, the mixture 
was allowed to stand at 4°C overnight. The precipitate was collected by 
centrifugation at 18,000 rpm with a JA 20 rotor and a J2-MI centrifuge for 30 min, 
dissolved in distilled water, and dialyzed against distilled water at 4°C for 5 days. 
By dialysis, the molecules of higher than 14,000 Da were maintained (dialysis 
pocket cut off size 14,000 Da). Water-insoluble components were removed by 
centrifugation at 18,000 rpm with a JA 20 rotor and a J2-MI centrifuge for 30 min 
and water-soluble components were lyophilized to obtain about 2.8 g pale 
brownish powder, designated Fraction A. The mycelia from the culture broth (10 1) 
were washed, homogenized and extracted with distilled water at 98°C to 100°C 
for 6 h. The filtrates obtained from the mycelia extraction were treated in the same 
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way as culture filtrates (Fig. 3.3) to produce about 0.9 g of extract (Fraction B). 
3. 2. 4. Purification of polysaccharide-protein complex 
A. Further fractionation 
DEAE-cellulose resin (Sigma,USA) was swollen with deionized distilled 
water (DDW) for overnight. The DEAE-cellulose resin was washed with 2 
volumes of 0.4 N HC1 solution. After decantation, the resin was washed with 
DDW until near neutrality. Then, resin was washed with 2 volumes of 0.4 N 
NaOH solution. After decantation, the resin was again washed with DDW until 
near neutrality. The treated DEAE-cellulose resin was packed into a column (2 x 
40 cm) with DDW. Fraction A (10 mg) in water was applied to the column 
packed. It was eluted with de-ionized water and a linear gradient ofNaCI solution 
at 90 ml/h. Absorbances were measured at 620 nm for polysaccharide using 
anthrone test (Kawagishi et al., 1990b) and at 600 nm for protein using the Lowry-
Folin method (Lowry et al., 1951). The positive fractions of anthrone test were 
collected and dialyzed against DDW for 5 days. The unbound component on 
DEAE-cellulose was eluted with DDW and 1.05 mg of a white powder, designated 
Fraction A-1, was obtained. The retained component on DEAE-cellulose was 
eluted with a gradient ofO to 2 M NaCl. The only retained component was eluted 
at concentration of 0.45 M NaCl and 3.85 mg of a pale brownish powder, 
designated Fraction A-2 (PSPC), was obtained. 
Anthrone test: 1 ml sample and 3 ml anthrone solution of sulfuric acid (2%) were 
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Fig. 3.3. Extraction and purification of fractions from T. lohayense 
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Absorbance was measured at 620 nm using Milton Roy Spectronic 3000. The 
standard curve was made with glucose (Kawagishi et al., 1990b). 
Lowry-Folin method. 1 ml sample and 5 ml reactive solution, including 2% NaCO3 
and 0.1 N NaOH : 1% CuSO4 5H2O and 2% C4H4O6KNa' 4H2O (50 : 1), were 
mixed, and stood at the room temperature for 10 min. Then, 0.5 ml Folin and 
Ciocalteu's phenol reagent (Sigma,USA) was added to the mixture, and this 
reactive solution was bathed for 30 min at 37°C. Absorbance was determined at 
600 nm using Milton Roy Spectronic 3000. The standard curve was made with 
bovine serum albumin (Lowry et al., 1951). 
B. Chemical purification 
a. Cetyltrimethylammonium hydroxide treatment (Chihara et al., 1970a) 
PSPC was dissolved in distilled water. To PSPC solution, aqueous 0.2 M 
cetyltrimethyl-ammonium hydroxide (CTA-OH), pH 13.2, was added with 
vigorous stirring until no more precipitate was formed (pH 11.5-12.8). The 
precipitate was collected by centrifugation at 12,000 rpm for 5 min, washed with ‘ 
75% ethanol, and resuspended in 3.3 M acetic acid. The insoluble part was 
removed by centrifugation at 12,000 rpm for 5 min, and 3 volumes of 100% 
ethanol was added to the supernatant. The precipitate formed was collected by 
centrifugation at 12,000 rpm for 5 min, and lyophilized, and then its polysaccharide 
and protein contents were analyzed. 
b. Protease treatment (Mizuno et al., 1990a) 
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The precipitate (10 mg) obtained from CTA-OH treatment was dissolved 
in 0.5 ml potassium phosphate buffer (0.25 M, pH 7.5). 50 mg of pronase E (a 
nonspecific protease from Streptomyces griseiis, 4 units/mg) in 4.5 ml of 
potassium phosphate buffer (0.25 M, pH 7.5) was mixed with 0.5 ml sample 
solution. The mixture was incubated at 37°C for 6 h. After boiling, the precipitate 
was removed from the mixture by centrifugation. The protein in supernatant was 
removed by the Sevag method (Staub, 1965) with chloroformM-butanol (24:1, 
v/v). The aqueous phase containing the sample was recovered and mixed with 3 
volumes of 100% ethanol. The final precipitate was collected and lyophilized, and 
then its polysaccharide and protein contents were analyzed. 
I 
3. 2. 5. Molecular mass determination 
Sepharose CL-4B was washed with sodium phosphate buffer (0.01 M, pH 
6.8) and degassed under vacuum. The gel was packed into a column (2.5 x 80 cm) 
with sodium phosphate buffer (0.01 M, pH 6.8). The molecular mass ofFraction , 
A-1 and Fraction A-2 (PSPC) was determined using gel filtration through ‘ 
Sepharose CL-4B which was suitable for the detection of molecular mass ranging 
from 1-10000 kDa. Dextrans with molecular mass of 2000 kDa, 515 kDa and 40.8 
kDa respectively were used as standards and sodium phosphate buffer (0.01 M, pH 
6.8) was used as eluant. Optical densities of the fractions and dextrans were 
measured at 620 nm (anthrone test). 
3. 2. 6. High performance liquid chromatography 
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High performance liquid chromatography (HPLC) was carried out with a 
Waters 510 liquid chromatography apparatus equipped with a ultrahydrogel 2000 
column (7.8 x 300 mm). The peaks were monitored with a Waters 410 differential 
refractometer. PSPC (10 mgAnl) was eluted using distilled water at the flow rate 
0.5 ml/min at 35°C. PSK (protein-bound polysaccharide) was used as control 
(Tsukagoshi et al., 1984). 
i 
3. 2. 7. SDS-polyacrylamide gel electrophoresis 
Prior to electrophoresis, PSPC was boiled for 5 min with 1% SDS in the 
presence of2-mercaptoethanol (2%). Bovine serum albumin was used as a marker 
in this experiment. Electrophoresis was carried out in 7.5% of SDS-polyacrylamide 
gel (80x100 mm) and Tris-glycine buffer (5 mM, pH 8.3) at 10-15 mA for 1.5 h. 
Gels were stained with Schiffs reagent (Dong et al.，1994) and Coomassie blue 
reagent respectively. 
Polysaccharide stainuig method: After electrophoresis, the gel was fixed in 12.5% 
trichloroacetic acid (TCA) for 30 min, and washed with distilled water three times. • 
The gel was immersed in PA solution (containing 10 g periodic acid dissolved in 
30 ml acetic acid and 970 ml distilled water) for 50 min, and washed with distilled 
water three times and stood in distilled water overnight. The gel was incubated for 
50 min in Schiffs reagent (Sigma,USA), and washed three times in freshly 
prepared 0.5% sodium metabisulfite. Polysaccharides were stained red. 
3. 2. 8. Ultraviolet scanning 
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PSPC was dissolved in distilled water and scanned at 200-300 nm using 
I 
Milton Roy Spectronic 3000. PSK (protein-bound polysaccharide) was used as the 
control. 
3. 2. 9. Chemical analysis 
A. Total polysaccharide and protein contents 
Polysaccharide and protein contents of fractions from T. lobayense were j 
quantitatively determined by the anthrone test and Lowry-Folin method ！ 
respectively. j 
i 
B. Total hexosamine contents i 
Hexosamine of fractions from T. lobayense was quantitatively determined 
by Elson-Morgan method (Chaplin and Kennedy, 1986). A standard curve was 
constructed to calculate the total hexosamine contents of fractions using 
glucosamine as standard. |： 
iff| 
Elson-Morgan method: Sample (5 mg) was dissolved in 1 ml of 3 N HC1 and air in 
the tube was substituted with nitrogen gas. The mixture was hydrolyzed for 15 h at 
100°C and dried. The dried sample was dissolved in 1 ml of H2O. The 0.4 ml of 
sample and standard glucosamine were mixed to 0.5 ml ofReagent A respectively. 
Each mixture was reacted at 100°C for 3 min. After cooling rapidly to room 
temperature, 3.0 ml ofReagent B was added to the mixture. The reactive solutions 
were incubated at 37°C for 20 min. After cooling to room temperature, the 
absorbance was determined at 585 nm. 
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Reagent A: 6.1 g of di-potassium tetraborate tetrahydrate was dissolved in 80 ml 
water, and then made up to 100 ml with water. 
Reagent B\ 1.5 ml of water and 11 ml of concentrated hydrochloric acid were 
mixed, and 87.5 ml of glacial acetic acid was added to the mixture. Then, 10 g of 
4-OSF,N-dimethylamino)-benzaldehyde was dissolved in the mixture. This mixture 
may be stored for several weeks. Dilute 10 ml to 100 ml with glacial acetic acid 
immediately prior to use. 
C. Monosaccharide analyses 
a. Gas chromatography (GC) 
Fraction A-1 and Fraction A-2 (PSPC) were hydrolyzed with 2 M 
trifluoroacetic acid (TFA) for 4 h at 100°C. The hydrolyzate was evaporated to 
remove the acid under N2. Fractions and standard sugars were run on GC system 
,j 
ofHP6890 series using column packed. 
【 i< 
b. Paper chromatography (PC) 
Fraction A-1 and Fraction A-2 (PSPC) were heated to 100°C for 6 h in l N 
H2SO4, and then, Ba(OH)2 was added to neutralize H2SO4. Fractions and standard 
sugar solutions were analyzed by paper chromatography using n-butyl 
alcohol/pyridine/water (6:4:3， by volume) as the solvent and 
diphenylamine/aniline/phosphoric acid as the dip reagent. 
‘ . 
D. Amino acid analysis 
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Fraction A-1 and Fraction A-2 (PSPC) were heated to 110°C for 24 h in 6 
M HCl and dried in a Speedvac concentrator. Then, the fractions were dissolved in 
Na-S reagent (containing sodium citrate 2%, hydrogen chloride 1%, thiodigIycol 
i 
0.5% and benzoic acid 0.1%, pH 2.0) and injected into an amino acid analyser 
) 
OBeckman 6300) for quantitative and qualitative analyses. 
E. Elemental analysis j. 
i「 
Fraction A-1 and Fraction A-2 (PSPC) powder were directly put into a 1 
[ 
Perkin-Elmer elemental analyser, and then percent content (w/w) of each element 
丨! j» 
in fraction was obtained. The mole value of each elememt was calculated related to | 
i= 
mole ratio ofcarbon (6) using the following formula: 
A (mole) = [ 6x C (MW) x A%] / [ C% x A (MW)] 
where A was the element detected except C, and C stood for carbon. 
I 
F. Infrared spectra (IR) | 
‘i 
Potassium bromide (KBr) film of PSPC was used for IR absorption _ 
measurements (Jin et al., 1991). About 1 mg of pure dry sample and 300 mg of 
pure dry KBr were mixed and followed by pressing into a disc. The whole IR 
spectrum (400-4500 cm] ) was recorded on a Nicolet Magna 750 FT-IR 
spectrophotomer. 
3. 2. 10. Experimental animals 
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Male ICR and inbred BALB/c mice (8-12 weeks old) were used in this 
study. The mice were divided into groups and housed under normal laboratory 
conditions (21 土 2。(：’ 12/12 h light-dark cycle) with free access to standard rodent 
！ i 
chow and water. j 
3. 2. 11. In vivo antitumor assay 
A. Anti-solid Sarcoma 180 test (Chihara et al., 1970a) j, 
li 
- 卜 Seven-day-old Sarcoma 180 ascites, 0.1 ml (1x10 cells/ml), was . j 
. !, 
transplanted subcutaneously into the right groin of each of eight male BALB/c (18 
丨. 
to 20 g) and eight male ICR (20 to 25 g) mice respectively. The fractions from T. 
lohayense were dissolved in distilled water respectively, and injected 
intraperitoneally or orally in the mice every day for 10 days, starting at 24 h after 
i : , 
tumor implantation or 3 days before or after tumor implantation. The control 、 
group of mice was similarly treated with distilled water. PSK was used as the 
positive control. At the end of week 2 or 5, the mice were killed and the tumors ^ 
: f j 
excised and weighed. Inhibition ratios (%) were calculated as [(E-n)/E] xlOO, , 
where E and n are the mean tumor weights in control and treated groups 
respectively. 
B. Anti-ascitic Sarcoma 180 test (Sugano et al., 1985) 
Seven-day-old Sarcoma 180 ascites, 0.1 ml (lxlO^ cells/ml), was injected 
intraperitoneally into male ICR (20 to 25 g) mice. PSPC was dissolved in distilled 
water, and injected intraperitoneally in the mice every day for 10 days, starting at 
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24 h after tumor implantation. The control group of mice was similarly treated 
with distilled water. Mortalities were recorded daily until all mice were dead. The 
survival ratios of mice were calculated using the following formula : 
Total survival number of mice in every group , …， 
Survival ratios (%) = ~ — — — r ~ r ^ - ^ — ~ " x 100% 
Total number of mice in every group 
3. 2. 12. Safety tests 
A. Acute toxicity 
Each group consisted of 5 male and 5 female BALB/c (18 to 20 g) mice. 
PSPC was injected intraperitoneally at 500 mg/kg once. The control group ofmice 
was similarly treated with distilled water. Mortalities were daily recorded for three 
consecutive days. 
B. Maximum tolerable capacity ^ 
II 
Each group was composed of 5 male and 5 female BALB/c (18 to 20 g) j j 
mice. Mice were forced fed PSPC (6 g/kg) twice a day. The control group of mice | 
was similarly treated with distilled water. Mortalities were daily recorded for three 
consecutive days. =: 
C. Sub-acute toxicity 
PSPC was injected intraperitoneally into each group of 5 male and 5 female 
BALB/c (25.0 土 0.5 g) and ICR (30.0 土 0.5 g) mice at 100 mg/kg for two weeks. 
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At the end of experiment, the weights of the body and organs of each mouse were 
recorded. The control group of mice was similarly treated with distilled water. 
D. Liver function test 
PSPC was injected intraperitoneally in male BALB/c (18 to 22 g) mice for 
10 consecutive days at the dose o f20 mg/kg/day. The control group of mice was 
similarly treated with distilled water. The mice were sacrificed on the second day 
( 
after completion of sample administration. Approximately 1-1.5 ml blood of a 
mouse was drained from the eyeball, centrifuged in 5,000 rpm for 5 min to harvest 
i 
the blood serum. The levels of serum glutamic pyruvic transaminase (SGPT) and ； 
glutamic oxaloacetic transaminase (SGOT) were measured according to the s 
method described by Reitman and Frankel (1957). ； 
I 
SGPTdetection: 0.1 ml serum and 0.5 ml GPT substrate solution (a-ketoglutarate, ^ 
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2 mM/L; DL-alanine, 200 mM/L) were mixed and incubated at 37°C for 30 min. 〔 
0 5 ml DNP (containing 19.8 mg 2,4-dinitrophenylhydrazine dissolved in 100 ml of | 
. 1 
1 N HCl) was added to the mixture and incubated at room temperature for 30 min. p 
Finally, the mixture and 5.0 ml of 0.4 N NaOH were mixed, and stood at room .; 
temperature for 10 min. The optical density was measured at 505 nm. Sodium : 
pyruvate was used for the standard curve. ’: 
SGOT detection: 0.1 ml serum and 0.5 ml GOT substrate solution (oc-
if 
ketoglutarate, 2 mM/L; L-aspartate, 200 mM/L) were mixed and incubated at 「 
370C for 1 h. 0.5 ml DNP was added to the mixture and incubated at room 
& ?i. 
temperature for 30 min. Finally, the mixture and 5.0 ml of 0.4 N NaOH were ^ 
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j 
I i ] 
. i 
mixed, and stood at room temperature for 10 min. The optical density was j 
measured at 505 nm. Sodium pyruvate was used for the standard curve. j 
E. Counting number of red and white blood cells 
PSPC (20 mg/kg/day) was injected intraperitoneally in male BALB/c (20 to 
22 g) and ICR (25 to 30g) mice for seven consecutive days. The mice were 
sacrificed on the second day after completion of sample administration. 1 ml blood 
was drained from the eyeball, heparin was used as anti-agglutinative agent. Red 
blood cells were counted using the cytometer under a microscope after the blood 
was diluted with 0.9% NaCl solution. White blood cells were counted using the 
cytometer under a microscope after the blood was treated and diluted with 3% 
acetic acid. The control group of mice was similarly treated with distilled water. 
The mitomycin C (1.5 mg/kg/day) was used as the positive control. 
i 
3. 2. 13. Statistical analysis ^ 
1 
Data obtained were analyzed using one-tail analysis of variance and match- i 
pair comparisons were further made by Student's t-test. The level of significance 
was taken a t P < 0.05. 
3. 3. Results 
i 
3. 3. 1. Extraction and purification 
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A pale brownish powder, designated Fraction A, was obtained after 丨 
lyophilization from the culture filtrates of T. lobayeme. The white powder from 
the cultured mycelia of T. lobayense was designated Fraction B. The elution il 
1 
profile ofFraction A is shown in Fig. 3.4. Fraction A was separated into Fraction 
A-1 and Fraction A-2 by DEAE-cellulose column. Fraction A-1 is a white powder, 
whereas Fraction A-2 is a pale brownish powder. Fraction A-2 showed the 




3. 3. 2. Biochemical analysis 1 
A. Molecular mass 1 
SI ilk I 
The molecular mass of the fractions was determined by Sepharose CL-4B , 
1 
. . 丨! 
gel filtration using dextran as standards. Dextran elution was showed in Fig. 3.5. | 
Fraction A-1 had a single peak on Sepharose CL-4B with a molecular mass of | 
•i 
about 27 kDa (Fig. 3.6, Fig. 3.7). Fraction A-2 also gave a single peak on the 
Sepharose CL-4B with a molecular mass ofabout 154 kDa (Fig. 3.8, Fig. 3.9). By t;-
using gel-chromatography on Sepharose CL-4B, Fraction A-2 gave a p 
polysaccharide peak, which differed slightly in position from the protein peak. This 
result also indicated that Fraction A-2 might be a polysaccharide firmly associated 
with the protein. HPLC analysis showed that Fraction A-2 had only a main peak, 
while PSK had two peaks (Fig. 3.10). Therefore, Fraction A-2 was considered to 
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Fig. 3.4. Elution pattern ofFraction A by DEAE-cellulose exchange chromatography 
The column was washed with de-ionized water to elute the unbound 
component (Fraction A-1), and the retained components were eluted 
with a salt gradient ofNaCl (0-2 M). The only retained component was 
designated Fraction A-2. 
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Fig. 3.5. Elution pattern of standard dextrans by Sepharose CL-4B gel filtration 
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Fig. 3.6. Elution pattern ofFraction A-1 by Sepharose CL-4B gel filtration 
The column was eluted with sodium phosphate buffer (0.01 M，pH 6.8). 
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Fig. 3.8. Elution pattern ofFraction A-2 by Sepharose CL-4B gel filtration 
The column was eluted with sodium phosphate buffer (0.01 M, pH 6.8). 
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Fig. 3.10. Elution patterns ofFraction A-2 (PSPC) and PSK by HPLC 
The column was eluted using distilled water at the flow rate 
0.5 ml/min at35。C. 
a. PSPC, b. PSK 
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B. Relationship of polysaccharide and protein in PSPC 
Polysaccharide and protein contents of PSPC before and after treatment 
with CTA-OH, pronase E and chlorofornVbutanol did not have any apparent 
change, and the ratios of polysaccharide and protein contents of PSPC always 
maintained 1.5. Moreover, the polysaccharide and protein bands of PSPC were 
located on the same spot on SDS-polyacrylamide gel electrophoresis (Fig. 3.11). 
The results showed that polysaccharide might be firmly bound to the protein in 
PSPC. The result of UV scan showed that PSPC and PSK, the well known 
protein-bound polysaccharides had prominent absorbance around wavelength 210 
nm. But, no absorbance peaks ofPSPC and PSK appeared at wavelength 280 nm 
though they all contain protein (Fig. 3.12). 
3. 3. 3. Chemical analysis 
The total polysaccharide and protein contents of the fractions were shown 
in Table 3.1. All fractions contained hexosamine although the amount was varying 
(Table 3.2). As shown in Table 3.3, these fractions were not glucan, but were 
probably unique heteroglycan. The protein portion of these fractions consisted of 
predominantly acidic amino acids such as aspartic acid and glutamic acid ( Table 3. 
4.). The result of the element analysis of these fractions was shown in Table 3.5. 
These fractions all contained carbon, hydrogen, oxygen, nitrogen and sulphur, the 
ratio of which demonstrated that they were carbohydrate containing a nitrogen 
compound. 
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Fig. 3.11. SDS-polyacrylamide gel electrophoresis ofPSPC 
a. PSPC, b. BSA protein 
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Fig.3.12. Ultraviolet spectra ofPSPC and PSK 
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Sources Samples Polysaccharide Protein 
(w/w, %) (w/w, %) 
Culture filtrates Fraction A 60.2 23.5 
Mycelia Fraction B 42.9 39.00 
Fraction A Fraction A-1 88.8 5.3 
Fraction A Fraction A-2 54.3 35.9 
(PSPC) 
': 





Table 3.2. Hexosamine contents of fractions from T. lobayense 
Sources Samples Hexosamine (w/w, %) 
Culture filtrates Fraction A 0.43 
Mycelia Fraction B 0.54 
Fraction A Fraction A-1 0.04 
Fraction A Fraction A-2 0.65 
(PSPC) 
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Table 3.3. Monosaccharide contents of the polysaccharide 
moiety of fractions from T. lohayense 
Monosaccharide Fraction A-1 Fraction A-2 
(PSPC) 
Galactose 44.3 43.6 
Glucose 37.2 27.6 
Arabinose ND 19.5 
Fucose 9.2 1.7 
Mannose 7.3 1.4 
Xylose ND 4.2 
Rhamnose ND 2.1 
The values stand for the percentage of peak area. 
ND: Not detected 
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Table 3.4. Amino acid composition in the protein moiety of 
fractions from T. lohayense 
Amino acid Fraction A-1 Fraction A-2 
(PSPC) 
Aspartic acid 6.5 12.7 
Threonine 5.7 8.8 
Serine 9.6 15.8 
Glutamic acid 6.0 18.3 
Proline 0.1 0.4 
Glycine 7.5 8.9 
Alanine 6.1 6.7 
Valine 3.0 4.6 
Methionine 0.2 0.3 
Isoleucine 1.7 3.4 
Leucine 2.2 2.3 
Tyrosine 0.7 0.3 
Phenylalanine 1.1 1.0 
Histidine 0.9 1.2 
Lysine 2.9 3.9 
Arginine 0.5 0.1 
Cystein ND ND 
Tryptophan ND ND 
The values stand for peak area of each amino acid. 
ND: Not detected 
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Table 3.5. Element contents of fractions from T. lohayense 
Elements Fraction A-1 Fraction A-2 
(PSPC) 
C 6 6 
H 12.37 11.37 
0 6.24 5.89 
N 0.13 0.54 
S 0.08 0.03 
The values are related to mole ratio of carbon. 
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In the IR spectra ofPSPC, 0 - H stretching frequency at 3300-3400 cm~\ 
C-H at 2900 cm"\ C=0 at 1630 cm"^ and C-H, C=0 at 1000-1100 cm"^ were 
observed (Fig. 3.13). The 0 - H peak at 3300-3400 cm"^ indicated that there were 
intermolecular hydrogen bonds in PSPC. 
3. 3. 4. In vivo antitumor activity 
Antitumor activity of the fractions obtained from T. lohayeme against the 
growth of solid Sarcoma 180 tumor transplanted in mice was shown in Table 3.6. 
Fraction A and Fraction A-2 (PSPC) showed strong antitumor activity in both ICR 
and BALB/c mice, with the most prominent effect in ICR mice. The effective dose 
ofPSPC was 20 mg/kg (Table 3.7). The pre-treatment or post-treatment of PSPC 
showed no significant difference on its antitumor activity (Table 3.8). The 
inhibitory ratio ofPSPC by intraperitoneal injection route was almost the same as 
that ofPSPC by oral administration route in ICR mice (Table 3.9). Figure 3.14 
demonstrated that the life span of the tumor-bearing mice treated by PSPC was 
longer than that of the control group. 
3. 3. 5. Safety evaluation 
Acute toxicity test showed that there were no deaths of mice after PSPC 
administration. PSPC maximum tolerable dose of per mouse orally administered 
was above 12 gy'kg a day. PSPC did not show any deleterious effects on mice 
because the behavior, physical fitness, body weight and organ weight of mice were 
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Fig. 3.13. Infrared spectra ofPSPC 
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Table 3.6. Antitumor activity of fractions from T. lobayense 
Treatment Mouse Dose Inhibition Complete 
groups strains (kgAiay) ratio (%) regression 
O^o. of mice) 
Distilled water ICR 0.2 ml 0/8 
(control) 
PSK “ 20 mg 93.3 3/8 
Fraction A ” 20 mg 84.5 1/8 
FractionB ” 20 mg 48.0 1/8 
Fraction A-1 ” 20 mg 39.5 2/8 
Fraction A-2 “ 20 mg 96.3 2/8 
OPSPC) 
Distilled water BALB/c 0.2 ml 0/8 
(control) 
PSK ” 20 mg 72.1 2/8 
Fraction A •丨 20 mg 64.3 1/8 
Fraction B ” 20 mg 21.4 0/8 
Fraction A-1 “ 20 mg 7.1 0/8 
Fraction A-2 “ 20 mg 57.1 0/8 
(PSPC) 
Mice were injected intraperitoneally with 20 mg/kg/day fractions and PSK for 
ten consecutive days respectively, starting 24 h after Sarcoma 180 subcutaneous 
implantation. The control group of mice was similarly treated with distilled water. 
The values are means 士 SD (n=8). 
ICR mice: Experiment was ended five weeks after fraction administration. 
BALB/c mice: Experiment was ended two weeks after fraction administration 
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Table 3.7. Effect of different dose ofPSPC on antitumor 
activity in ICR mice 
Dose (kg/day) Inhibitory ratio (%) 
Distilled water (0.2 ml) 
10 mg 62.3 
20 mg 91.9 
50mg 92.7 
100 mg 77.9 
Mice were treated intraperitoneally with different dose 
PSPC/kg/day for ten consecutive days, starting 24 h after 
Sarcoma 180 subcutaneous implantation. The control group 
of mice was similarly treated with distilled water. 
The values are means 土 SD (n= 8). 
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Table 3.8. Effect of different treatment time ofPSPC on antitumor 
activity in ICR mice 
Treatment 
groups Dose (kg/day) Inhibitory ratio (%) 
Distilled water 
(control) 0.2 ml 
Pre-treatment 20 mg 86.2 
post-treatment 20 mg 85.6 
Pre-treatment: Mice were injected intraperitoneally with 20 mg/kg/day 
PSPC for ten consecutive day, starting 3 days before tumor implantation. 
Post-treatment: Mice were injected intraperitoneally with 20 mg/kg/day 
PSPC for ten consecutive day, starting 3 days after tumor implantation. 
The control group of mice was similarly treated with distilled water. 
The values are means 土 SD (n= 8). 
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Table 3.9. Effect of different treatment route ofPSPC on antitumor 
activity in ICR mice 
Treatment Dose (kg/day) Inhibitory ratio (%) 
groups 
Distilled water 
(control) 0.2 ml 
Oral treatment 20 mg 90.1 
Intraperitoneal 20 mg 88.9 
treatment 
Oral treatment: Mice were treated orally with 20 mg/kgAiay PSPC 
for ten consecutive day, starting 24 h after tumor implantation. 
Intraperitoneal treatment: Mice were treated intraperitoneally with 
20 mg/kg/day PSPC for ten consecutive day, starting 24 h after 
tumor implantation. 
The control group of mice was similarly treated with distilled water. 
The values are means 土 SD (n= 8). 
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Fig. 3.14. Effect ofPSPC on the life span ofICR mice after intraperitoneal 
implantation of Sarcoma 180 cells 
’ PSPC was given intraperitoneaIly at 20 mg/kg/day to ICR mice 
for ten consecutive days. Distilled water was given as control. 
The values are means 土 SD (n=8). 
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not significantly different between the treated and control groups of mice for two 
weeks in a sub-acute toxicity test (Table 3.10). 
Afler PSPC administration, the activities of SGOT and SGPT were not 
significantly different between the treated and control groups of mice (Table 3.11). 
The number of white and red blood cells also had no significant changes between 
the treated and control groups of BALB/c and ICR mice (Table 3.12). However, 
the number of white and red blood cells was affected by mitomycin C (1.5 
mg/kg/day) in BALB/c mice, but not in ICR mice. 
3. 4. Discussion 
Antitumor polysaccharides have been reported to occur in the fruiting 
bodies, cultured mycelia and culture filtrates of basidiomycetes (Jong and 
Birmingham, 1990). These antitumor polysaccharides vary in their chemical 
composition, structure and antitumor activity (Whistler et al., 1976). In the present 
study, the culture filtrates of a local mushroom, Tricholoma lohayense are found 
to possess antitumor activity. Fraction A of the culture filtrates from T. lohayeme 
is detected against both the solid and ascitic Sarcoma 180 growth in vivo. Fraction 
B extracted from the cultured mycelia of T. lobayeme does not show any obvious 
antitumor activity. The result is in accord with the other on schizophyllan obtained 
from the culture filtrates of Schizophyllum commune (Whistler et al., 1976). It is 
suggested that the culture filtrates of some basidiomycetes contain the specific 
antitumor components which are not present in the cultured mycelia and fruiting 
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Table 3.10. Effect of PSPC on body and organ weights o fBALB/c and ICR mice 
Treatment Mouse Dose Body Spleen Liver 
groups strains (kg/day) weight (g) weight (g) weight (g) 
Distilled water 
(control) ICR 0.2 ml 33.4土4.1 0.22±0.08 2.510.9 
PSPC ” 100mg 32.7土1.9 0.22土0.03 2.7t0.5 
BALB/c 26.5±1.5 0.14土0.01 1.9土0.2 
Distilled water 
(control) 0.2 ml 
PSPC ” 100mg 27.3±2.8 0.15土0.06 1.7士0.4 
1 
Mice were treated intraperitoneally with 100 mgy^ kgAJay PSPC for two consecutive 
weeks. The control group of mice was similarly treated with distilled water. 
The values are means 士 SD (n= 10), P > 0.05. 
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Table 3.11. Effect ofPSPC on serum transaminase activity in BALB/c 
mice 
Treatment SGPT SGOT 
groups Dose (kgAday) (unit/ml) (unit/ml) 
Distilled water 
(control) 0.2 ml 65 ± 19 188±25 
PSPC 20 mg 58土7 182土8 
Mice were treated intraperitoneally with 20 mg/kg/day PSPC for ten 
consecutive days. The control group of mice was similarly treated 
with distilled water. 
The values are means 土 SD (n= 4), P > 0.05. 
1 
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Table 3.12. Effect ofPSPC on the number of blood cellsin mice 
Treatment Mouse Dose White cells/ml Red cells /ml 
groups strains (kg/day) (x 10^) (x 10^) 
Distilled water 
(control) ICR 0.2 ml 4.8士0.7 7.5土1.2 
PSPC “ 20 mg 4.4土2.1 7.5±2.2 
Mitomycin C “ 1.5 mg 4.0土1.3 5.0土2.4* 
Distilled water BALB/c 0.2 ml 7.2土0.9 11.8±3.1 
(control) 
PSPC “ 20 mg 6.8土1.4 10.7土4.1 
Mitomycin C “ 1.5 mg 3.0±1.6* 5.3土2.1* 
_ 
Mice were injected intraperitoneally with 20 mg/kg/day PSPC and 
1.5 mgy'kg/day mitomycin C for seven consecutive days respectively. 
The control group of mice was similarly treated with distilled water. 
The values are means 土 SD (n=5), *P < 0.05. 
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bodies. The antitumor components may be a special secretory products of 
basidiomycetes (Liu et al., 1995). 
Fraction A is purified into two sub-fractions, Fraction A-1 and Fraction A-
2. The antitumor activity ofFraction A-2 (PSPC) is higher than that ofFraction A-
1. The molecular mass ofPSPC is about 154 kDa, but Fraction A-1 is only about 
27 kDa. Therefore, it appears that the polysaccharide of high molecular mass is 
important for antitumor activity (Adachi et al., 1990b; Kim et al., 1990). 
PSPC is a polysaccharide-protein complex. It is rich in various 
monosaccharides, such as galactose, glucose, arabinose, xylose, rhamnose, fucose 
and mannose. The polysaccharide moiety ofPSPC is an unique heteroglycan, This 
is in line with the report that the polysaccharide moiety of antitumor extracts from 
the fruiting body of T. gigantetim is also a heteroglycan (Mizuno et al., 1995a). 
However, the polysaccharide moiety of the commercially available antitumor 
agents, such as lentinan (Chihara et aI., 1970a)，schizophyllan (Komatsu et al., 
1969) and PSK (Tsukagoshi et al.，1984), is p-glucan. The relationship between 
« 
the composition and antitumor activity of polysaccharides remains to be 
researched. The protein content of PSPC (Fraction A-2) is higher than that of 
Fraction A-1. PSPC exhibits strong antitumor activity whereas Fraction A-1 is 
ineffective. The result suggests that the antitumor activity of the fraction is 
probably, in part, due to the presence of protein units as complex, which has also 
been shown in some other basidiomycetes (Kawagishi et al., 1990a). The protein 
portion ofPSPC consists of predominantly acidic amino acids such as aspartic acid 
and glutamic acid. Although protein contents and amino acid compositions of 
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various antitumor polysaccharide complexes are variable, they share a common 
characteristic, that is, predominant acidic amino acids in their protein portion. This 
common characteristic was shown by the amino acid analysis of antitumor 
polysaccharide complexes from Coriolus versicolor (Tsukagoshi et al., 1984 )， 
Cordyceps ophioglossoides (Ohmori et al., 1988a), Favoliis alveolarius ( Chang 
et al., 1988)，Phellimis lhiteus (Song et al., 1995) and Leritimis edodes (Jin et al., 
1991). Therefore, it is of much interest to examine whether the acidic amino acids 
are indeed related to antitumor activity. 
It is reported that the sulphated lentinan completely abolishes antitumor 
activity in transplanted allogeneic or syngeneic tumor models, such as Sarcoma 
180 (ICR) or P815 (DBA/2) in vivo, whereas the non-sulphated lentinan exhibits 
strong antitumor activity. Nevertheless, the sulphated lentinan has been shown to 
have anti-HIV function (Yoshida et al., 1988). In the present studies, the ratio of 
sulphur to methionine in Fraction A-1 is 5 times more than that in PSPC (Fraction 
i 
A-2). However, antitumor activity ofPSPC is much higher than that ofFraction A- j 
1. This result which shows very low antitumor activity of highly sulphated 
polysaccharide from T. lohayeme is in line with that found in lentinan research 
(Yoshida et al., 1988). Therefore, it is worth mentioning that Fraction A-1 also 
possesses no or very low anti-tumor activity, but whether its highly sulphated 
polysaccharide content has any anti-HIV ability deserves further studies. 
PSPC shows the polysaccharide peak coinciding with the protein peak on 
DEAE-cellulose and Sepharose CL-4B columns. The polysaccharide and protein 
contents of PSPC before and after treatment with CTA-OH, pronase E and 
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chlorofonWbutanol do not apparently change. The polysaccharide and protein 
bands of PSPC are located on the same spot on SDS-polyacrylamide gel 
electrophoresis. These results show that PSPC is a protein-bound polysaccharide. 
In addition, the result of UV scan shows that PSPC and PSK have obvious 
absorbance peaks around wavelength at 210 nm, but not at 280 nm though they all 
contain protein. The protein content of PSK is 38% (Ebina and Murata, 1992), 
whereas that of PSPC is 35.9%. It is possible that polysaccharides interfere with 
the absorbance of protein. This result further indicates that PSPC is a protein-
bound polysaccharide. 
The IR spectra studies provide a simple and convenient method to analyze 
the phenomenon of hydrogen bond. 0 - H stretching frequency at about 3560 cm"^ 
exhibits the presence of intramolecular hydrogen bond, whilst the 0 - H stretching 
frequency at 3300-3400 cm"^ indicates the presence of intermolecuIar hydrogen 
bonds (Bellamy, 1975; Hatakeyama et al., 1976; Mohamed and Jack, 1986). The 
ER spectra ofPSPC show that PSPC has characteristic groups of polysaccharides \ 
m 
and intermolecuIar hydrogen bonds. The intermolecuIar hydrogen bonds in PSPC 
indicate that it is a complex polymer. 
PSPC exhibits strong antitumor activity in both ICR and BALB/c mice, 
with the most prominent effect in ICR mice. Some reports indicate that the 
antitumor activity of polysaccharides depends partly on the strains of mouse to 
which they are administered (Whistler et al., 1976). Lentinan strongly inhibits the 
growth of Sarcoma 180 in Swiss albino mice, whereas it is somewhat less effective 
in BALB/c mice and ineffective in C57BL/6 mice (Chihara, 1992). PSK exhibits 
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antitumor activity on Sarcoma 180 in ICR mice, but not in AKR mice. Growth of 
Sarcoma 180 is suppressed to the intermediate extent in C57BL/6, SL and 
C3H/He mice by PSK administration (Yoshikumi et al., 1975). In the present 
study, the antitumor effectiveness of PSPC is also affected by the tumor-bearing 
host. 
For the search of antitumor polysaccharides, Sarcoma 180 is generally used 
as the basic screening model. In the anti-solid Sarcoma 180 experiment, it is found 
that tumor growth is not influenced during the first 5-8 days by PSPC treatment. 
After this initial experimental period, tumor growth is adversely influenced. This 
seems to be an indication for the indirect, non-cytotoxic effect which is due to the 
immunomodulating capacity ofPSPC. Although the anti-solid Sarcoma 180 is the 
common characteristics of antitumor polysaccharides, only some antitumor 
polysaccharides have the ability of anti-ascitic Sarcoma 180 (Sugano et al., 1985). 
It is found that various acidic antitumor polysaccharides significantly inhibit the 
growth of ascites tumor (Sakagami et al., 1987; Sakagami et al., 1991b). PSPC is 
eluted using NaCl solution on DEAE column, and thus it is a weak acidic 
polysaccharide. The weak acidic characteristic of PSPC might be related to its 
anti-ascitic Sarcoma 180 activity. The inhibitory ratio ofPSPC against Sarcoma 
180 is a marker dose-dependence under low concentration. However, the dose-
dependent inhibitory ratio is not obvious under high concentration. Hosts for 
polysaccharides have a suitable dose, the excessive dose is no effective. The study 
oflentinan also identifies this inference (Chihara et aI., 1970a). It was reported that 
the tumor-inhibitory ratios of lentinan at 1 mg/kg and 5 mg/kg doses in vivo were 
82 
95.1% and 97.5% respectively, whereas the tumor-inhibitory ratio oflentinan at 25 
mg/kg dose was only 73%. Because lentinan do not have cytotoxicity in vivo and 
in vitro (Chihara et al., 1970a; Sakagami et al., 1990), that high dose lead to the 
decrease of the tumor-inhibitory ratio remains to be researched. 
The acute toxicity and sub-acute toxicity tests show that PSPC is non toxic 
in vivo. PSPC has no significant effects on body weight, liver and spleen weight of 
mice. However, it is reported that an algal antitumor polysaccharide from 
Gloiopeltis tenax increases the spleen weight of mice after intraperitoneal 
administration (Ren et al., 1995). These results show that the effects of different 
polysaccharides on normal mice are also different. 
Liver has an action of detoxification. Serum amine transferase is an enzyme 
marker for liver function. After the liver is damaged, the release of SGPT and 
SGOT into circulation is increased (Chiu et al., 1988). The enzymic activity of 
SGPT and SGOT of mice exhibits no significant changes after PSPC 
administration. Therefore, PSPC does not affect the liver function of mice. 
I 
During chemotherapy, one of the important monitoring indexes is the blood 
cell numbers in the body. PSPC has no significant effects on the white and red cell 
number ofblood though its dose (20 mgy'kg/day) is thirteen times more than that of 
chemotherapy agent (mitomycin C, 1.5 mg/kg/day) in ICR and BALB/c mice. 
Therefore, PSPC is quite safe as compared with mitomycin C. 
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3. 5. Summary 
An antitumor polysaccharide-protein complex (PSPC) was isolated and 
characterized from the culture filtrates of T. lohayeme which was a new record of 
mushroom species found in Hong Kong. The SDS-polyacrylamide gel 
electrophoresis, UV scan and CTA-OH, pronase E and chlorofornVbutanol 
treatments of PSPC showed that PSPC behaved as a protein-bound 
polysaccharide, with a molecular mass estimated to be 154 kDa by gel filtration. 
PSPC contained 54.3% polysaccharide, which consisted of galactose, glucose, 
arabinose, xylose, rhamnose, fucose and mannose, and 35.9% protein which was 
composed of predominantly acidic amino acid such as aspartic and glutamic acids. 
The infrared spectra ofPSPC indicated that PSPC had the characteristic groups of 
polysaccharide and intermolecular hydrogen bonds. PSPC could inhibit the growth 
of Sarcoma 180 implanted in mice intraperitoneally and subcutaneously, with no 




Antitumor, Immunomodulating and other Biological Activities of 
Polysaccharide-Protein Complex (PSPC) from Tricholoma lobayense 
4. 1. Introduction 
A polysaccharide-protein complex (PSPC) isolated from the culture 
filtrates ofT. lobayense inhibits the growth ofboth solid and ascites Sarcoma 180 
in mice, with no sign of toxicity in vivo (refer to Chapter 3). Therefore, the 
antitumor mechanism ofPSPC deserves to be probed. At present, it is generally 
<i 
believed that polysaccharides inhibit the growth of tumor cells of the host by 
restoring or enhancing the immune defense system. 
In recent years, there are diverse antitumor drugs used clinically, such as 
geranylgeraniol (Ohizumi et al., 1995), cisplatin (Barry et al., 1990; Evans and 
Dive, 1993)，camptothecin-11 (Yoshida et al., 1993) and bufalin (Jing et al., 1994)， 
which can induce apoptosis in tumor cells. Since cells that have undergone 
apoptosis are rapidly recognized and engulfed by macrophages before cell lysis, 
they can be removed without inducing inflammation. Macrophages appear to bind 
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apoptotic fragments preferentially, probably due to changes in the expression of 
sugar residues on the surface of apoptotic cells. Therefore, apoptosis-induced 
agents are expected to be ideal antitumor drugs (Ohizumi et al., 1995). Whether or 
not the antitumor polysaccharides from mushrooms can induce apoptosis of tumor 
cells deserves fiarther investigation. 
In addition to extensive studies on the antitumor and immunomodulating 
activities of polysaccharides, other aspects of biological and pharmacological 
actions ofpolysaccharides including antiviral, antimicrobial, free radical scavenging 
and hepatic protective effects have also been actively explored (Chihara, 1992; Hu 
et al., 1992; Ohno et al., 1996; Wei et al., 1996). Many antitumor polysaccharides 
from mushrooms are found to have antiviral and antimicrobial activities. However, 
free radical scavenging activity of polysaccharides from mushrooms is seldom 
studied though the scavenging activity of extracts from plants has been reported 
(Afanas,ev et al., 1989; Maeda et al., 1992; Zheng et al.，1993; Zhang et al., 1995; 
Masaki et al., 1995). Free radicals have been proposed to induce cellular damages 
# 
which may play a role in pathogenesis of heart diseases, rheumatoid arthritis, 
tumors and inflammatory disorders as well as in aging processes (Heilmann et al., 
1995). Thus, the search for effective, non-toxic substances with free radical 
scavenging activity has been active in the past years. Among various naturally 
occurring substances, polysaccharides from mushrooms deserve special attention 
of research. 
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In this chapter, the immunomodulating, antitumor and other biological 
activities of polysaccharide-protein complex (PSPC) from Tricholoma lobayense 
wil l be evaluated. 
4. 2. Materials and Methods 
4 .2 .1 . Experimental animals , 
Male ICR and inbred BALB/c mice (8-12 weeks old) were used in this , 
study. The mice were divided into groups and housed under normal laboratory 
conditions (21 土 2°C，12/12 h light-dark cycle) with free access to standard rodent 
chow and water. 
4. 2. 2. Cultivation of tumor cells 
P815 (mastocytoma cell), L929 (mouse fibroblast cell), melanoma, HL-60 
(human leukemia cell)，PU5-1.8 (mouse monocyte macrophage), H3B (hepatoma 
i 
*•« 
cell) and Sarcoma 180 tumor cell lines were maintained in RPMI medium 
supplemented with 10% fetal bovine serum, 100 ng/ml streptomycin and 100 
KJ/ml penicillin at 37°C in a humidified atmosphere supplied with 5% CO2. 
4. 2. 3. Preparation of peritoneal exudate cells and splenocytes 
A. Normal mice 
PSPC was injected intraperitoneally in mice for 10 consecutive days at the 
dose of 20 mg/kg/day. The mice were sacrificed on the second day after 
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completion of sample administration. Peritoneal exudate cells (PEC) were 
recovered by lavage of the peritoneal cavity with ice cold Hank's balanced salt 
solution (HBSS) and the splenocytes were obtained by homogenizing spleen with 
ice cold HBSS. Erythrocytes were removed by an incubation with 0.83% NH4Cl-
Tris buffer at 37°C for 5 min. After washing twice with phosphate-buffer saline 
(PBS) containing 1% fetal bovine serum, the cells were suspended in RPMI 
medium containing 10% fetal bovine serum. PEC and splenocytes were counted by 
, 
I 
the trypan blue dye exclusion method under a microscope for immunological , 
experiments. The control group of mice was similarly treated with 0.9% NaCl 
solution. 
B. Tumor-bearing mice 
Sarcoma 180 cells were injected intraperitoneaIly and maintained in the 
peritoneum of male ICR mice. An ICR mouse was sacrificed on the seventh day 
after intraperitoneal inoculation of Sarcoma 180 and the ascitic fluid was 
<*t' 
collected. The cells were washed three times, and the cell suspension was diluted 
to lxlC)7 cells/ml. Then, 0.1 ml (lxlO^ cells/ml) Sarcoma 180 cells were 
transplanted subcutaneously into the right groin of male BALB/c mice. PSPC was 
injected intraperitoneaIly in mice for 10 consecutive days at the dose of 20 
mg/kg/day, starting at 24 h after the tumor implantation. The mice were sacrificed 
on the second day after completion of sample administration. PEC were recovered 
by lavage of the peritoneal cavity with ice cold Hank's balanced salt solution 
(HBSS) and the splenocytes were obtained by homogenizing spleen with ice cold 
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HBSS. Erythrocytes were removed by an incubation with 0.83% NH4CI-Tris 
buffer at 37°C for 5 min. After washing twice with phosphate-buffer saline (PBS) 
containing 1% fetal bovine serum, the cells were suspended in RPMI medium 
containing 10% fetal bovine serum. PEC and splenocytes were counted by the 
trypan blue dye exclusion method under microscope for immunological and 
antitumor experiments. The control group of mice was similarly treated with 0.9% 
NaCl solution. 
4. 2. 4. Mitogenic response o fT cells (Liu et al., 1989) 
T cells were isolated from murine splenocytes in the flasks coated with 
anti-B cells antibody. Macrophages were removed by adherence on a culture well 
for 2 h. Then, T cells (2xl0^ cells/ml) were cultured in the presence of 0，10, 20 
and 40 ng/ml ofCon A respectively for 48 h before they were pulsed with 0.5 ^Ci 
t 
of [^H] thymidine (specific activity 5 ^Ci/mmole, Amersham, UK) for 6 h. The ^ 
cells were then harvested onto a glass fiber filter using a cell harvester, and the ！ 
f* 
radioactivity was determined using a Beckman scintillation counter (reference). 
The mitogenic activity was expressed as mean counts per minute (CPM). 
4. 2. 5. Response of peritoneal exudate cells 
A. Phagocytic function of peritoneal exudate cells (Liu et al., 1993) 
Peritoneal exudate cells (PEC) were diluted with RPMI medium containing 
10% fetal bovine serum, and then seeded in 96-well microplates with 0.5xl0^ 
lxlO^ and 2xl0^ cells/O.lml/well respectively. The cells were incubated at 37°C in 
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a humidified atmosphere supplied with 5% CO2 for 24 h. The cultures were 
replaced with fresh HBSS containing 0.005% neutral red for 1 h, and the neutral 
red uptake by the cells was measured using a microplate reader (3550 Bio-Rad 
Microplate Reader, USA) at 540 nm. 
B. Production of nitric oxide (Liu et al., 1993) 
Nitric oxide 0>K)) is a colorless gas at the room temperature and pressure , 
(boiling point, -151.7°C at 1 atm). Its maximum solubility in water is similar to 
that ofpure oxygen, 2-3 mM (Fukuto, 1995). It exists for about six to ten seconds 
and then is converted by oxygen into nitrates and nitrites. NO amount is estimated 
by the reaction of nitrates or nitrites and Griess reagent (1% sulfanilamide in 5% 
H3PO4-O.l% naphthalene-ethylenediamine dihydrochloride). The production of 
NO was easily induced in rodent macrophages. Lipopolysaccharide (LPS) is 
usually used as an inducer o fNO. In this experiment, the peritoneal exudate cells 
were collected counted and resuspended in D M E M medium containing 10% fetal 
I W 
bovine serum, 100 IU/ml penicillin and 100 ng/ml streptomycin, but no phenol red. 
The cells (2xl0^ cells/0.2ml/weIl) were allowed to adhere onto the surface of the 
wells of a 96-well culture plate for 1 h before they were challenged with LPS 
(Sigma,USA) of 0, 10 and 1000 ng/ml respectively for 24 h. Cell-free culture 
medium (0.1 ml) was then allowed to react with 50 ^il Griess reagent for 10 min 
before the absorbance was read at 540 nm using a microplate reader. 
C. Inhibition ofthe proliferation of P815 cells (Liu et al., 1989) 
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The assay of the tumoricidal activity of peritoneal exudate cells (PEC) was 
designed as follows: A range of dilution of PEC (lxlO^-8xlO^ cells/ml) from 
control and PSPC treated tumor-bearing mice was prepared. Aliquots (0.2 ml) of 
the cell suspension were allowed to adhere onto a 96-well culture plate at 37°C for 
3 h with the culture medium as a control. The culture weIIs were washed 
vigorously with warm phosphate buffer solution (PBS) to remove cells which had 
not adhered, and the adherent PEC were activated by incubation with lymphokine 
> 
preparations for 24 h. The activated PEC were further incubated with P815 cells 
(lxlO^ cells/ml) for 24 h before they were pulsed with 0.5 ^tCi [^H] thymidine for 6 
h. The tumoricidal activity ofPEC was assayed as mean counts per minute (CPM) 
by a Beckman scintillation counter. The inhibition ratios of P815 cells were 
calculated by using the following formula: 
CPM of treated sample 
Inhibition ratios(%) = ( 1 - ^ ^ , , ^ : — — V )x lOO% 
CPM of control sample 
Lymphokine preparation: Twenty ml of normal spleens (lxlO^ cells/ml) from mice , 
？ t 
were cultured in a 75 cm^ culture flask in the presence of 10 ngAnl Con A for 3 h. j 
The culture medium was removed, and the lymphocyte monolayer was rinsed 
carefully with warm phosphate-buffered saline to remove excess Con A. The cells 
were further incubated for an additional 24 h at 3TC with 20 ml of fresh 
supplemented RPMI. After incubation, the cell-free culture medium was sterilised 
by passing through a 0.22 ^im millipore filter and the lymphokine-containing 
medium was collected for anti-P815 cell growth assay. 
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D. Production of tumor necrosis factor (Liu et al., 1993) 
Tumor necrosis factor (TNF-a) is routinely produced in peritoneal exudate 
cells (PEC) and the stroma of normal tissues. In this study, PEC (lxlO^ cells/ml) 
from control and PSPC treated tumor-bearing mice were collected and incubated 
in the presence of 1 ng/ml of LPS for 0，30, 60, 90, 120 and 150 min respectively. 
The cell-free medium containing TNF-a was collected for anti-L929 cell growth 
assay. 
L929 cells (lxlO^ cells/ml) were cultured at 37°C for 24 h, treated with 2 
pig/ml actinomycin D for 2 h and further incubated with 0.1 ml culture medium 
containing TNF-a (1:400 dilution, v/v) for 24 h with the culture medium as a 
control. The viability of adherent cells was measured by staining with 0.1 ml of 
crystal violet for 5 min, rinsing 3 times with warm PBS and then reading the 
absorbance at 595 nm with a microplate reader. TNF-a bioactivity was defined as 
! 
inhibition ratios ofL929 cells according to the following formula: i [ 
Inhibition ratios of L929 cells (%) == [(A-B)/A] x 100% 
•«.. 
where A was absorbance of viable cells without treatment，and B was absorbance 
ofviable cells with medium containing TNF-a. 
4. 2. 6. In vitro antitumor assay 
A. Cytotoxicity (Sugano et al., 1985) 
Sarcoma 180 cells were diluted to make 2xl0^ cells/O.lml/welI in RPMI 
medium containing 10% fetal bovine serum. Then, the cells were cultured in the 
presence of 100，250, 500 and 1000 ^ig/ml ofPSPC respectively for 24 h at 37°C 
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in a humidified atmosphere supplied with 5% CO2. The numbers of viable cells 
were counted by the trypan blue dye exclusion method. Inhibition ratio was 
calculated as follows : 
Inhibition ratio (%) = [ (A-B)/A] x 100% 
where A was number of viable cells of control group, and B was number of viable 
cells ofPSPC-treated group. 
m 
B. Antiproliferative activity (Wang et al., 1995) 
Tumor cell lines including melanoma, PU5-1.8 and H3B were cultured at 
lxlO^ cells/O.lml /well in the presence of 30, 60, 120 and 240 ng/ ml ofPSPC 
respectively for 24 h before they were pulsed with 0.5 nCi/lOpil/well of [^B] 
thymidine for 6 h. The uptake of the radioisotopes by the cells was determined as 
mean counts per minute by a Beckman scintillation counter. The antiproliferative 
activity indexes were calculated as follows: .； 
Antiproliferative activity index = [(A-B)/A] x 100% 
I •« 
where A was the average counts per minute of the control group and B was the 
average counts per minute ofPSPC-treated group. 
4. 2. 7. Transmission electron microscope 
A. Sarcoma 180 in vivo 
Male ICR mice were inoculated subcutaneously into the left groin with 
Sarcoma 180 cell suspensions of0.1 ml (lxlO^ cells/ml) for establishment of solid 
tumor. PSPC was injected intraperitoneally in mice for 10 consecutive days at the 
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dose of 20 mg/kg/day, starting at 24 h after the tumor implantation. The control 
group of mice was treated only with 0.9% NaCl solution. At the end of 4th week, 
the mice were sacrificed, and the tumors were isolated, cut into small blocks and 
fixed in ice-cold 2% glutaraldehyde in phosphate buffer for 12 h. These small 
blocks were then post-fixed in ice-cold 1% osmium tetroxide in phosphate buffer 
for 2 h, dehydrated in graded ethanol and embedded in Spurr's epoxy resin. 
Sections were cut on a Reichert ultramicrotome and stained with saturated uranyl 
acetate and lead citrate. All electron micrographs were taken under JEM-1200 EX 
II. 
B. Human leukemia HL-60 cells in vitro 
HL-60 cells were cultured at lxlO^ cells/ml in the presence of 100 pig/ml of 
PSPC for 24 h with the culture medium as a control before they were collected by 
centrifugation. Cells were fixed in ice-cold 2% glutaraldehyde in phosphate buffer 
i 
. . i 
for 2 h, and then washed twice in phosphate buffer. They were post-fixed in ice-
« 
cold 1% osmium tetroxide in phosphate buffer for 2 h, rinsed twice in phosphate 
bufFer, dehydrated in graded ethanol and embedded in Spurr，s epoxy resin. 
Sections were cut on a Reichert ultramicrotome and stained with saturated uranyl 
acetate and lead citrate. All electron micrographs were taken under JEM- 1200 EX 
II. 
4. 2. 8. Evaluation of other biological activities 
A. Antimicrobial test (Sakagami et al., 1991a) 
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Escherichia coli B and Staphylococcus atireiis were cultured in Luria broth 
(LB, 10 g Bacto-tryptone, 5 g Bacto-yeast extracts and 10 g NaCl per litter broth) 
at 37°C on a rotary shaker at 180 rev/min for 24 h. Male ICR mice (20 to 25 g) 
were pretreated with PSPC intraperitoneally for 3 consecutive days at the dose of 
A 
20 mgy'kg/day before they were inoculated intraperitoneally with 0.2 ml (1x10 
cells/ml) Escherichia coli B or Staphylococcus aureus respectively. The control 
group of mice was similarly treated with 0.9% NaCl solution. Mortalities were • 
recorded daily until all mice were dead. The survival ratios of mice were calculated 
using the following formula : 
Total survival number of mice in every group ㈣書 
Survival ratios (%) = ~ ~ : ; r ^ — — r ~ ~ r " ^ — ~ ~ - x 100% 
Total number of mice in every group 
B. Free radical scavenging test 
a. Superoxide radical generation using PMS-NADH system (Li et al., 1992) 
The superoxide radicals were generated in a PMS-NADH system by the 
oxidation o fNADH and assayed by the reduction ofNBT. In this experiment, the • 
superoxide radicals were generated in 3 ml of Tris-HCl buffer (16 mM, pH 8.0)， 
which contained 78 |^iM p-nicotinamide adenine dinucleotide (reduced form, 
NADH), 50 piM nitroblue tetrazolium Q ^ T ) , 10 ^iM phenazin methosulfate 
^PMS) and 5, 20 and 80 ^ig/ml PSPC respectively. The color reaction of 
superoxide radicals and NBT was detected at OD 560 nm using Milton Roy 
Spectronic 3000. Vitamin C and glucose were used as controls. The inhibition 
ratio ofsuperoxide generation was calculated using the following formula: 
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Inhibition ratio (%) = (A-Al) /A x 100% 
where A was the absorbance of control group, and A1 was the absorbance of test 
sample groups. 
b. Hydroxyl radical generation using vitamin C-CuSO4 system (Hu et al., 1992) 
The hydroxyl radicals were generated in vitamin C-CuSO4 system by the 
reduction of Cu】+ and were assayed by the oxidation of cytochrome C. In this • 
experiment, the hydroxyl radicals were generated in 3 ml of 0.15 mM sodium 
phosphate buffer (pH 7.4)，which included 100 i_iM vitamin C, 100 |^iM CuSO4, 12 
“ M cytochrome C and 200, 400 and 600 ng/ml PSPC respectively. The mixture 
was incubated at 25°C for 90 min. The transmittance of color change of 
cytochrome C was measured at 550 nm using Milton Roy Spectronic 3000. 
Thiourea and glucose were used as controls. The inhibition ratio of hydroxyl 
radical generation by thiourea was taken as 100%. The inhibition ratio of hydroxyl 
I I 
radical generation was calculated using the following formula: 
• 
T 一 丁 2 
Inhibition ratio (%) = ~ ^ X 100% 
1 一 1 i 
where T was the transmittance of hydroxyl radical (OH ) generation system, T1 
and T2 were the transmittance of control (no OH generation) and test sample 
systems respectively. 
C. Lipid peroxidation 
a. Preparation of mouse liver microsomes 
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Male BALB/c mice (8-12 weeks old) were sacrificed by cervical 
dislocation. The liver was rapidly homogenized in ice-cold 0.25 M sucrose and 
centrifuged at 5,000 rpm for 20 min at 4°C. The supernatant obtained was 
centrifuged at 32,000 rpm with SW 60 Ti rotor of XL-80 ultracentrifuge for 60 
min at 4°C. The microsomes were washed using ice-cold 0.15 M KC1, and then, 
stored at -20°C. Protein content of microsomes was measured by Lowry method 
OLowry et al., 1951). • 
b. Detection ofl ipid peroxidation (Li et al., 1992) 
The product of microsomal lipid peroxidation was malondialdehyde 
(MDA). Microsomes (200-300 ^ig/ml) were incubated at 37°C for 60 min with 30， 
60 and 120 ng/ml PSPC respectively, 10 ^ M FeS04 and 0.1 mM ascorbic acid in 
1.0 ml potassium phosphate buffer solution (0.2 M, pH 7.4). The reaction was 
stopped by 20% (w/v) trichloroacetic acid (TCA, 1.0 ml) and 0.67% (w/v) 2-
thiobarbituric acid (TBA, 1.5 ml) in succession, and the solution was then heated 
鲁 
at 100°C for 15 min. Afler centrifugation of precipitated protein, the color reaction 
o f M D A - T B A complex was detected at OD 532 nm using Milton Roy Spectronic 
3000. Butylated hydroxyanisole and glucose were used as control in this 
experiment. 
D. Antifatigue test (Yang and Wang, 1994) 
Fifteen male BALB/c mice (20±1.0 g) were used in this test. PSPC was 
injected intraperitoneally in mice for 10 consecutive days at the dose of 20 mg 
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/kgAiay. The control group of mice was similarly treated with 0.9% NaCl solution. 
After the end ofPSPC administration, the mice, which were tied with rubber o f l . 6 
g to their tail, were put into a glass tank filled with water (300 mm x 200 mm x 
260 mm, water depth 230 mm, temperature 20±10C) to start swimming. 
Swimming time of each mouse was recorded. The mice were considered as 
exhausting energy when their heads can not float above the water surface for thirty 
seconds. The difference of swimming time between PSPC-treated group and . 
control group was compared. 
E. Hepatic protective effect 
PSPC was injected intraperitoneally in male ICR mice (25±1 g) for 10 
consecutive days at the dose of 20 mg/kgAday. The control group of mice was 
similarly treated with 0.9% NaCl. Carbon tetrachloride (CCl4) was used to induce 
acute hepatic damage to evaluate PSPC hepatic protective effect in this 
experiment. CCl4 was dissolved in olive oil ( 40%, v/v), and 0.6 ml/kg of CCl4 was 丨 
I 9 
injected intraperitoneally in mice after completion of PSPC administration. The 
mice were sacrificed 24 h after CCl4 intake and the hepatic protective effect was 
evaluated. Approximately 1-1.5 ml of blood was drained from the eyeball, 
centrifuged in 5,000 rpm for 5 min to harvest the blood serum. The levels of serum 
glutamic pyruvic transaminase (SGPT) and serum glutamic oxaloacetic 
transaminase (SGOT) were measured according to the method described by 
Reitman and Frankel (1957). 
98 
SGPTdetection: 0.1 ml serum and 0.5 ml GPT substrate solution (a-ketoglutarate, 
2 mM/L; DL-alanine, 200 mM/L) were mixed and incubated at 37°C for 30 min. 
0.5 ml DNP (containing 19.8 mg 2,4-dinitrophenylhydrazine dissolved in 100 ml of 
1 N HCl) was added to the mixture and incubated at room temperature for 30 min. 
Finally, the mixture and 5.0 ml of 0.4 N NaOH were mixed, and stood at room 
temperature for 10 min. The optical density was measured at 505 nm. Sodium 
pyruvate was used for the standard curve. , 
I 
SGOT detectiorr. 0.1 ml serum and 0.5 ml GOT substrate solution (a- \ 
j 
ketoglutarate, 2 mJVL^; L-aspartate, 200 mMA.) were mixed and incubated at 
37°C for 1 h. 0.5 ml DNP was added to the mixture and incubated at room 
temperature for 30 min. Finally, the mixture and 5.0 ml of 0.4 N NaOH were 
mixed, and stood at room temperature for 10 min. The optical density was 
measured at 505 nm. Sodium pyruvate was used for the standard curve. 
I 
4. 2. 9. Statistical analysis 
• 
Data obtained were analyzed using one-tail analysis of variance and match-
pair comparisons were further made by Student's t-test. The level of significance 
was taken at P < 0.05. 
4. 3. Results 
4.3.1. Immunomodulating activity 
A. Mitogenic response o fT cells 
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PSPC had no substantial effect on the mitogenic activity of the normal mice 
OFig. 4.1). However, the mitogenic activity of the tumor-bearing mice was lower 
than that of the normal mice when T cells were cultured in the presence of 10, 20 
and 40 ^ig/ml Con A respectively (Fig. 4.2). PSPC could significantly (P<0.01) 
restore and increase the T cell mitogenic activity of the tumor-bearing mice in the 
same Con A concentrations. 
'1 
1 
B. Phagocytic function of peritoneal exudate cells 
! 
Phagocytic function of peritoneal exudate cells (PEC) was related to the 
inhibitory ratios of tumor. PSPC also had no substantial effect on the PEC 
phagocytic function of the normal mice (Fig. 4.3). The PEC phagocytic function of 
the tumor-bearing mice was lower than that in normal mice in any cell 
concentration (Fig. 4.4). PSPC had significant (P<0.01) ability to restore and 
increase the depressed phagocytic function of the tumor-bearing mice. 
i： 
i' 
C. Production of nitric oxide 
Nitric oxide (NO) is a fairly nonpolar molecule which would be expected to 
freely diffuse through membranes (Fukuto, 1995). It has cytotoxic activity. PSPC 
had significant effect on the released amount of NO of the normal mice (P<0.01) 
^Fig. 4.5). The released amount o fNO in both tumor-bearing mice and the tumor-
bearing mice treated with PSPC was higher than that of the norma! mice (P<0.01) 
(Fig. 4.6) when LPS concentrations were 10 and 1000 ngAnl respectively. 
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Fig. 4.1. Effect ofPSPC on T cell mitogenic activity in normal mice 
PSPC was given intraperitoneally at the dose of 20 mg/kg/day 
for ten consecutive days in normal mice. The control group of 
mice was similarly treated with 0.9% NaCl solution. 
Each column represents the means 土 SD, P > 0.05 compared 
to control group (n=6). 
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Fig. 4.2. Effect ofPSPC on T cell mitogenic activity in tumor-bearing mice 
Mice were injected intraperitoneally with 20 mg/kg/day PSPC for ten 
‘consecutive days, starting 24 h after Sarcoma 180 subcutaneous 
implantation. The control group of mice was similarly treated with 
0.9% NaCl solution. Each column represents the means 土 SD, (n=6). 
T cell mitogenic activity of tumor-bearing mice treated with PSPC was 
compared to that of normal and tumor-bearing mice, (*P < 0.05). 
T cells mitogenic activity of tumor-bearing mice was compared to that 
of normal mice, (P < 0.05). 
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Fig. 4.3. Effect ofPSPC on phagocytic function of peritoneal exudate cells 
in normal mice 
PSPC was given intraperitoneally at the dose of 20 mg/kg/day 
for ten consecutive days in normal mice. The control group of 
mice was similarly treated with 0.9% NaCl solution. 
Each column represents the means 土 SD, P > 0.05 compared 
to control group (n=6). 
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Fig. 4.4. Effect ofPSPC on phagocytic function of peritoneal exudate cells (PEC) 
in tumor-bearing mice 
Mice were injected intraperitoneaIly with 20 mg/kg/day PSPC for ten 
consecutive days, starting 24 h after Sarcoma 180 subcutaneous 
implantation. The control group of mice was similarly treated with 
0.9% NaCl solution. Each column represents the means 土 SD，(n=6). 
PEC phagocytic function of tumor-bearing mice treated with PSPC was 
compared to that of normal and tumor-bearing mice, (*P < 0.05). 
PEC phagocytic function of tumor-bearing mice was compared to that 
of normal mice, (P < 0.05). 
104 
0.3 r * 
• Control j 
SPSPC ^ H 
* ^ ^ H 
E 0.2 _ ^ ^ ^ m 
o ^ H T ^ m ^ ^^m ^ ^ B u^  ^ ^ H ^ ^ 9 
Q 了 ^ M ^ H 
〇 n ^ ^ H ^fl 
01 - ^ H ^ H 
T ^ ^ _ 圓 ^ m 
P " H • • 
K®fi§8xxx»i »§«888888888 1¾¾^¾¾¾¾^ 
^ H ^ H ^ ^ H 
^ H | | ^ H ^ ^ H 
^^ ^^ ^^ ¾ 憩 ^ ^^ M^ ^^ ^^ ^^ 3^ 
0 m ^ ^ ^ ^ m 
0 10 1000 
Concentration of LPS (ng/ml) 
Fig. 4.5. Production of nitric oxide in peritoneal exudate cells of control and 
normal mice treated with PSPC 
PSPC was given intraperitoneally at the dose of 20 mg>^ k:g/day 
for ten consecutive days in normal mice. The control group of 
mice was similarly treated with 0.9% NaCl solution. 
Each column represents the means 士 SD, * P < 0.05 compared 
to control group (n=6). 
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Fig. 4.6. Production of nitric oxide (NO) in peritoneal exudate cells (PEC) of control 
and tumor-bearing mice treated with PSPC 
Mice were injected intraperitoneally with 20 mgy1cgAiay PSPC for ten 
consecutive days, starting 24 h after Sarcoma 180 subcutaneous 
implantation. The control group of mice was similarly treated with 
0.9% NaCl solution. Each column represents the means 土 SD, (n=6). 
NO production in PEC of tumor-bearing mice treated with PSPC was 
compared to that of normal and tumor-bearing mice, (*P < 0.05). 
NO production in PEC of tumor-bearing mice was compared to that of 
normal mice, (P < 0.05). 
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D. Inhibitory activity against P815 and L929 cells 
The anti-P815 cell actions of both the tumor-bearing mice and the tumor-
bearing mice treated with PSPC were significantly (P<0.01) higher than that of the 
normal mice in peritoneal exudate cells (4xl0^ and 8xl0^ cells/ml) (Fig. 4.7). The 
relationship of direct ratio between the released amount o f N O and the growth of 
anti-P815 cells of peritoneal exudate cells could be observed by comparing Fig. 4.6 
and Fig. 4.7. The more NO is released, the higher the inhibitory ratio ofP815 cells. 
TNF-a strongly inhibited the growth of L929 cells. PSPC significantly 
(P<0.01) increased TNF-a production in the PEC of the tumor-bearing mice after 
incubation with PLS for 30, 60’ 90, 120 and 150 min respectively (Fig. 4.8). 
However, TNF-a production in the PEC of the tumor-bearing mice was inhibited. 
4. 3. 2. In vitro antitumor action 
There was no significant inhibition of growth of Sarcoma 180 cells that 
were cultured in the presence of500 ng/ml of PSPC in vitro (Table 4.1). PSPC 
produced a marked dose-dependent inhibition of [^]-thymidine incorporation in 
PU5-1.8, H3B and melanoma tumor cell lines (Fig. 4.9). However, PSPC 
possessed a more potent antiproliferative activity against PU5-1.8 and H3B cells 
than melanoma cells. 
4. 3. 3. Observation on tumor regression induced by PSPC 
A. Sarcoma 180 />? vivo 
i 
i . • | 
107 
100 厂 ~»~Normalmice 
^ * • ^ 
色 —A— Tumor-bearing mice 
兰 QQ _ -#-Tumor-bearing mice treated with PSPC ① 
i 6°. ^K;P==^ 
I 40 - A ^ 1 
i : l ^ ^ 
0 2 4 6 8 
PEC number(10®) 
Fig. 4.7. Inhibiton ofP815 cell growth of macrophage activating factor-activated 
peritoneal exudate cells from control and tumor-bearing mice treated 
with PSPC. 
Mice were injected intraperitoneally with 20 mg/kg/day PSPC for ten 
consecutive days, starting 24 h after Sarcoma 180 subcutaneous 
implantation. The control group of mice was similarly treated 
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Fig. 4.8. Inhibition ofL929 cell growth by TNF-containing media produced by 
peritoneal exudate cells from control and tumor-bearing mice treated 
with PSPC. 
Mice were injected intraperitoneally with 20 mg/kg/day PSPC for ten 
consecutive days, starting 24 h after Sarcoma 180 subcutaneous 
implantation. The control group of mice was similarly treated 
with 0.9% NaCl solution. Peritoneal exudate cells were stimulated 
with LPS for 0, 30，60，90, 120 and 150 min respectively. The values 
are means 土 SD (n=6). 
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Table 4.1. Effect ofPSPC on Sarcomal80 cells in vitro 
Samples Concentration Inhibition ratio (%) 
(HgAnl) 
Control Medium 
PSPC 100 3.7 
PSPC 250 - 2 . 6 
PSPC 500 3.5 
PSPC 1000 46.5 
Sarcomal80 cells were cultured in the presence ofPSPC for 24 h 
at 37°C. The values are means 土 SD (n = 6). 
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Fig. 4.9. Antiproliferative activity ofPSPC against tumor cell lines in vitro 
Tumor cells were cultured in the presence ofPSPC for 24 h at 
37°C before they were pulsed with [^H] thymidine for 6 h. The 
values are means 土 SD (n=6). 
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I t is reported that apoptotic levels of Sarcoma 180 fall within a consistent 
range between 0.3% and 2.2% respectively in Sarcoma 180-bearing mice (Bowen 
and Bowen, 1990). In the present experiment, apoptotic cell death was seldom 
found in the tumor of the control group (Fig. 4.10a). After PSPC administration, 
the number of apoptotic cell death significantly increased in the tumors (Fig. 
4.10b). The earliest fine structural changes of apoptosis were the condensation and 
margination of the chromatin，followed by the loss of structural integrity of the 
inner nuclear membrane and the appearance of chromatin cleavage. The number of 
macrophages significantly increased in the tumor site where macrophages could 
rapidly phagocytose apoptotic fragments (Fig. 4.10b). 
B. Human leukemia HL-60 cells />? vitro 
The untreated HL-60 cells observed in this study were morphologically 
diverse, but they showed no signs of modifications of their fine structural 
characteristics (Fig. 4.11a). After PSPC treatment, the morphological changes 
happened in HL-60 cells (Fig. 4.11b). The chromatin condensation and nuclear 
fragmentation of HL-60 cells were found in the presence ofPSPC. Therefore, the 
administration ofPSPC might induce apoptosis ofHL-60 cells. 
4. 3. 4. Other biological actions 
A. Antimicrobial activity 
PSPC significantly increased the survival time of mice infected with 




Fig. 4.10. Regressive action ofPSPC on Sarcoma 180 cells in vivo 
Mice were injected intraperitoneally with 20 mg/kg/day PSPC for ten 
consecutive days, starting 24 h after Sarcoma 180 subcutaneous 
implantation. The control group of mice was similarly treated 
with 0.9% NaCl solution. 
a. Sarcomal80 cells from the control group of mice, Bar = 2\xm 
b. Sarcomal80 cells from the treated group of mice, Bar = 2^im 
A. Condensation and margination of chromatin 
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Fig. 4.11. Inhibition action ofPSPC on HL-60 cells in vitro 
a. Untreated HL-60 cells cultured at 24 h, Bar = 2|_im 
b. HL-60 cells cultured in the presence of 100 ^ig PSPC /ml 
for 24 h, Bar = 2^im 
A. Condensation and margination of chromatin 
B. Loss of structural integrity of nuclear membrane 
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Fig. 4.12. Effect ofPSPC on life span after intraperitoneal inoculation of 
Escherichia coli B in ICR mice 
Mice were injected intraperitoneally with 20 mg/kg/day PSPC 
for three days before inoculation of Escherichia coli B. The 
control group of mice was similarly treated with 0.9% NaCl 
solution. 
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Fig. 4.13. Effect ofPSPC on life span after intraperitoneal inoculation of 
Staphylococcus aureus in ICR mice 
Mice were injected intraperitoneally with 20 mg/kg/day PSPC 
for three days before inoculation of Staphylococcus aureus. 
The control group of mice was similarly treated with 0.9% 
NaCl solution. 
116 
antimicrobial activity was induced when the mice were pretreated with 20 mg/kg 
of PSPC by intraperitoneal route, three days before Escherichia coli B or 
Staphylococcus aureus inoculation. 
B. Free radical scavenging activity 
In the present experiments, two kinds of free radicals, superoxide and 
hydroxyl radicals, were studied. The superoxide radicals were generated in a PMS-
NADH system and assayed by the reduction of NBT. PSPC exhibited the 
superoxide radical scavenging activity in this system, vitamin C was used as the 
positive control, glucose was acted as the negative control (Table 4.2). The 
hydroxyl radicals were generated in a vitamin C-CuSO4 system and determined by 
the oxidation of cytochrome C. The hydroxyl radical scavenging activity was 
observed in presence of PSPC, thiourea was used as the positive control, glucose 
was acted as the negative control (Table 4.3). 
C. Lipid peroxidation 
Malondialdehyde, formed from the breakdown of polyunsaturated fatty 
acids, serves as a convenient index for determining the extent of lipid peroxidation 
(Esterbauer, 1985; Prasad et al., 1996). PSPC did not inhibit microsomal lipid 
peroxidation (Table 4.4). Butylated hydroxyanisole was used as the positive 
control, glucose were used as the negative control. 
D. Antifatigue action 
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Table 4.2. Effect ofPSPC on superoxide radical generation 
Inhibition 
Samples Conc. (^igAnl) ratio (%) 
Control Buffer 
PSPC 5 17.6 
PSPC 20 20.1 
PSPC 80 24.6 
Vitamin C 40 67.0 
Glucose 80 2.8 
The values are means 土 SD (n = 3). 
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Table 4.3. Effect of PSPC on hydroxyl radical generation 
Inhibition 
Samples ratio (%) 
OH (Buffer) 
OH + Thiourea (760ng/ml) 100.0 
OH + PSPC (200pig/ml) 13.5 
OH + PSPC (400^g/ml) 24.3 
OH+PSPC(600|_ig/ml) 25.1 
OH + Glucose(400|_igAnl) 0 
The values are means 士 SD (n = 3). 
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Table 4.4. Effect of PSPC on microsomal lipid peroxidation 
Inhibition 
Samples Conc. pig/ml ratio % 
Control Buffer 
PSPC 30 5.3 
PSPC 60 3.7 
PSPC 120 1.0 
Butylated hydroxyanisole 9 x 10"^ 44.9 
Glucose 60 1.7 
The values are means 土 SD (n = 3). 
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There was marked difference in duration of swimming between control and 
PSPC-treated groups (Table 4.5). The duration of swimming in PSPC-treated mice 
was significantly longer than that of control mice. 
E. Hepatic protective effect 
As shown in Table 4.6，CCU caused significant increases in the SGPT and 
SGOT activities. However, the degree of CCl4-induced hepatotoxicity was not 
decreased by the coadministration ofPSPC in ICR mice. 
4. 4. Discussion 
4. 4. 1. Immunomodulating activity 
It is generally accepted that the immune system, especially cell-mediated 
immunity, plays an important role in antitumor activity. It is well known that some 
polysaccharides from mushrooms can enhance the specific functions of 
macrophages and T cells, exhibiting an antitumor effect through 
immunomodulation. Macrophages have a fundamental protective function and 
release a vast number of factors, including cytokines, nitric oxide and so on. T 
cells also play a critical role in both protective and autoimmune responses (Takeda 
et al., 1994). 
PSPC could recover or increase the immunological activity of tumor-
bearing mice (Liu et al.，1996b). This is in line with a similar result obtained from 
studies on the effect of a (l~>6)-P-D-glucan-protein complex isolated from 
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Table 4.5. Effect ofPSPC on swimming time ofBALB/c mice 
Samples Swimming time (min) 
Control 105 土 16 
PSPC 155土29* 
Mice were treated intraperitoneally with 20 mgy^kg/day PSPC 
for ten consecutively days. The control group of mice was 
similarly treated with 0.9% NaCl solution. 
The values are means 土 SD (n =15), * P< 0.05. 
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Table 4.6. Effect ofPSPC on CCU -induced changes of serum 
transaminase activity in ICR mice 
Treatment SGPT SGOT 
groups (unit/ml) (unit/ml) 
Distilled water 
(control) 65土18 188土24 
Distilled water + CCU 396土12 319±31 
PSPC + CCl4 382 ±27 312土11 
Mice were injected intraperitoneally with 20 mgA:gAlay PSPC for 
ten consecutive days. The control group of mice was similarly treated 
with 0.9% NaCl solution. 
Mice were scarified 24 h after 0.6 ml/kg of CCl4 (40%, v/v) intake. 
The values are means 土 SD (n= 4)，P > 0.05. 
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Agariciis blazei on the normal and tumor-bearing mice (Itoh et al., 1994). 
Therefore, it is well recognized that the immune response is frequently suppressed 
in the tumor-bearing animals. The cellular basis of immunosuppression in tumor-
bearing mice is due to the T cell activity (Heba et al., 1976). The activity o f T 
cells, as measured by the helper T cell function on the induction of hapten-specific 
antibody responses to the hapten-thymus-dependent carriers, is markedly 
suppressed as compared with the normal mice (Heba et al., 1976). However, the 
suppression of T cell activity in the tumor-bearing mice is almost completely 
prevented by lentinan administration (Heba et al., 1976). Moreover, the effect of 
delayed type hypersensitivity response in the tumor-bearing animals is significantly 
reduced as compared with normal animals (Tsukagoshi et al., 1984). PSK restores 
the depressed response to the normal level. Therefore, this experimental system 
may be used for the search of immunopotentiators relevant to tumor 
immunotherapy in light of the effect of antitumor polysaccharides on the immune 
suppression in the tumor-bearing animals. 
In addition, PSPC exhibits indirect cytotoxic activity against P815 cells and 
L929 cells by activating PEC to release the mediators, such as nitric oxide (NO) 
and TNF-a. NO and TNF-a have been shown to be critically involved in 
tumoricidal activity against P815 cells and L929 cells (Keller et al., 1990). In the 
present study, it is found that the released amount of NO is influenced by the 
exogenous stimulation such as tumor inoculation and PSPC treatment. 
Furthermore, the more NO is released, the higher the inhibitory ratio ofP815 cells. 
The mechanism of NO action suggested that NO might suppress mitochondrial 
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respiration ofP815 cells (Kilbourn et al., 1984). However, It was also found that 
after NO was secreted by the activating macrophages, it, in turn, stimulated the 
macrophages to kill tumor cells, bacteria and fungi (Takema et al., 1991; Snyder 
and Bredt, 1992). TNF-a production in the PEC of the tumor-bearing mice is 
inhibited. PSPC increases TNF-a production in the PEC of the tumor-bearing 
mice, but it does not affect TNF-a production in the PEC of the normal mice. The 
mechanism of TNF-a against tumor cells has been widely investigated. It is 
estimated that the binding of TNF-a to high-affinity cell surface receptors is 
directly toxic to tumor cells. The toxicity may be a result of the production of free 
radicals. Normal cells respond to TNF-a by synthesizing superoxide dismutase, an 
enzyme that participates in the inactivation of free radicals. In contrast, many 
tumor cells fail to make superoxide dismutase in response to TNF-a . Thus, part of 
the explanation of selective tumor cell killing by TNF-a may be loss of responses 
in these cells that serve to protect normal cells (Abbas et al., 1991). Although 
TNF-a and NO are all the mediators produced by PEC, the mechanism of their 
action is different and remains obscure. 
4. 4. 2. Antitumor activity 
A. In vitro antitumor action 
The results of the present studies show no significant inhibition of the 
growth of Sarcoma 180 cells that have been cultured in the presence of 500 ^ig/ml 
ofPSPC in vitro. The concentration of PSPC effective towards Sarcoma 180 in 
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vitro was above 500 ^ig/ml, a level which could not be achieved in vivo by the 
administration of20 mg/kg PSPC in mice. Therefore, the anti-Sarcoma 180 action 
of PSPC would not be cytocidal, but it was probably host-dependent. However, 
PSPC possesses potent antiproliferative activity against PU5-1.8, H3B and 
melanoma cells in the presence of 120 ^ig/ml of PSPC in vitro. Thus, PSPC 
exhibits as well the effect of direct cytotoxicity. The present study also shows that 
different tumor cell lines are different in their sensitivity to the antitumor 
polysaccharides. 
B. Observation on tumor regression 
Apoptosis, or programmed cell death, is an active, energy-dependent 
process through which living cells participate in their own destruction and is 
initiated by a variety of physiological and pharmacological stimuli (Kerr et al., 
1972; Bowen and Bowen, 1990). A fundamental component of this response is the 
stereotypical degradation of genomic DNA to oligonucleosomal fragments (Jarvis 
et al., 1994). PSPC appears to indirectly induce Sarcoma 180 apoptosis in vivo, 
and directly induce HL-60 cell apoptosis in vitro. With regard to the mechanism of 
apoptosis induced by PSPC in Sarcoma 180 solid tumor, it is probable that PSPC 
stimulates various immune responses in the tumor-bearing mice，for example 
potentiation ofthe production of cytokines such as TNF-a and M-CSF (Liu et al., 
1996a)，and the proliferation of T lymphocytes. It is known that T-lymphocyte-
derived IL-2 could activate natural killer CNK) cells and cytotoxic T-lymphocytes 
(CTL). NK cell killing and CTL-mediated killing are reported to undergo similar 
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morphological changes as those of apoptosis (Bowen and Bowen, 1990). 
Therefore, it is suggested that antitumor activity ofPSPC may be attributed to the 
host-mediated immunomodulation. In addition, it has been reported that some 
antitumor agents induce the apoptosis of HL-60 cells in vitro (Ohizumi et al., 
1995; Lin et al., 1995). After HL-60 cells are treated with PSPC, the condensation 
and margination of chromatin are observed following the loss of structural integrity 
of inner nuclear membrane and the appearance of chromatin cleavage. This result 
shows that the effect of PSPC on the death of HL-60 cells might involve 
apoptosis. It has been reported that TNF-a induces apoptosis ofhuman HL-60 and 
U-937 leukemia and the murine L929 and WEHI fibrosarcoma cell* lines (Elias et 
al., 1988; Chen et al., 1995). TNF-a is also found to enhance radiation killing in 
tumor cells, in vivo and in vitro, in part by increasing the fraction of cells 
undergoing apoptosis (Hallahan et al., 1989; Weichselbaum et aI., 1994). Another 
mechainsm of TNF-a against tumor cells is suggested that TNF-a employs the 
sphingomyelin pathway to effect signal transduction by its receptor (Jarvis et aI., 
1994). This pathway is initiated by hydrolysis of plasma membrane sphingomyelin 
to ceramide by the action of a sphingomyelinase. That ceramide acts as an 
intracellular messenger induces apoptotic DNA fragmentation and the death of cell 
lines (Kim et al.，1991; Dressier et al., 1992; Kolesnick and Golde, 1994; Jarvis et 
al., 1994). Whether the mechanism of PSPC-induced apoptosis of HL-60 cells is 
similar to that ofTNF-a deserves to be further studied. 
4. 4. 3. Other biological activities 
127 
PSPC has a potent antimicrobial activity against Escherichia coli B and 
Staphylococcus aureus. It has been reported that the antimicrobial activity of 
polysaccharides is related to the activation of phagocytic function of macrophages 
(Tsukagoshi et al., 1984). In addition, a recent study shows that NO is an 
important effector molecule on antimicrobial effect of macrophages (Ohno et al., 
1996). The antimicrobial activity of PSPC thus seems to be related to the 
activation of the phagocytic function and the NO production of macrophages. 
Superoxide and hydroxyl radicals are two most representative free radicals. 
In cellular oxidation reactions, superoxide radical is normally formed first, and its 
effects can be magnified because it produces other kinds of cell-damaging free 
radicals and oxidizing agents. However, the damaging action of hydroxyl radical is 
the strongest among free radicals. Therefore, these two kinds of free radicals have 
been extensively studied. Although the free radical scavenging activity of 
polysaccharides, such as PSP (Hu et al., 1992) and PSK (Sakagami et al., 1992) 
have been reported, their action mechanism is still not fully understood. It is 
known that phenolic compounds chemically synthesized and phenolic compounds 
from plants, such as phenylpropaniod glycosides (Zhou and Zheng，1991; L i et al., 
1992; Hiramoto et al., 1996; Wang, P. et al., 1996), may react with superoxide by 
an one-electron transfer mechanism or hydrogen abstraction mechanism to give the 
semiquinones. Hence, the scavenging activity of phenylpropaniod glycosides for 
superoxide may be due to their reductive activities which may be related to the 
number of phenolic hydroxyl groups and the conjugated system (Wang, P. et al., 
1996). However, it is not clear whether the mechanism of superoxide scavenging 
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by mushroom polysaccharides is similar to that of phenolic compounds. Moreover, 
free radicals are the main factors involved in fatigue of the body (Yang et al.， 
1994). The present study shows that PSPC has a significant antifatigue action. 
Antifatigue action of PSPC in vivo seems to be consistent with its free radical 
scavenging activity in vitro. 
Lipid peroxidation of liver microsomes is a complex process (Esterbauer, 
1985; Giorgio et al., 1991). It involves the formation and propagation of lipid 
radical, the uptake of oxygen, the rearrangement of the double bonds in 
unsaturated lipid, and the eventual destruction of membrane lipids, which produce 
the breakdown products such as maIondialdehyde in liver microsomes. PSPC does 
not show any antioxidative activity probably because it can not inhibit liver 
microsomal lipid peroxidation in vitro. It is possible that in the present in vitro 
experiment, although Fe^Vvitamin C system induces the production of microsomal 
peroxyl radical (Afanas'ev et al., 1989), PSPC appears to have no ability in 
scavenging peroxyl radical. PSPC does not exhibit any significantly protective 
effect for CCU-induced hepatotoxicity. CCU induces lipid peroxidation of liver 
microsomes and results in significant augmented levels of SGPT and SGOT. No 
hepatic protective effect of PSPC />/ vivo is consistent with the absence of 
antioxidative activity in vitro. Therefore, the relationships among the antitumor, 
free radical scavenging and antioxidative activities of polysaccharides might not be 
directly correlated. Notwithstanding, mushroom polysaccharides may provide a 
promising source for research and development of potential drugs for combating 
free radical pathogenesis. 
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4. 5. Summary 
PSPC had immunomodulating actions in vivo. It restored and increased 
phagocytic function of PEC and mitogenic responses of T cells of the tumor-
bearing mice. It also exhibited indirect cytotoxicity against P815 and L929 by 
activating PEC to release the mediators, such as nitric oxide CNO) and TNF-a. 
The direct cytotoxicity of PSPC was observed in PU5-1.8, H3B, HL-60, 
melanoma and Sarcoma 180 tumor cell lines. However, the different tumor cell 
lines were differentially sensitive to PSPC. The antiproliferative activity against 
PU5-1.8 cells was in the presence of 60 ng/ml ofPSPC, whereas the concentration 
of PSPC against Sarcoma 180 cells iti vitro was above 500 ^ig/ml. Electron 
microscopic observation on tumor regression showed that PSPC indirectly induced 
Sarcoma 180 apoptosis in vivo, and directly induced HL-60 cell apoptosis />7 vitro. 
Therefore, the antitumor activity of PSPC might be due to both host-mediated 
immunomodulating action and direct cytotoxicity. 
PSPC had the potent antimicrobial activity against Escherichia coli B and 
Staphylococcus aureus by the phagocytic function and NO production of 
activating macrophages. It also had the scavenging activities on superoxide and 
hydroxyl radicals generated in vitro. It was found that PSPC increased the stamina 
of the mice. However, PSPC did not exhibit any antioxidative and hepatic 
protective effects. Hence’ studies on immunomodulating, antitumor and other 
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biological activities of PSPC might provide a possible scientific basis for its 
neutriceutical and clinical application. 
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Chapter 5 
Induction of Gene Expression of Immunomodulating Cytokines by 
Polysaccharide-Protein Complex (PSPC) from Tricholoma lohayense 
5. 1. Introduction 
Considerable experimental evidences support that the antitumor action of 
mushroom polysaccharides is due to the potentiation of host immune system 
through the regulation of cytokines and activation of the complement system. It is 
found that there are many immunomodulating cytokines present in the host (Vilcek 
and Le, 1992). The gene expression of these cytokines is affected by many internal 
or external factors. OL-2 glucan extracted from Omphalia lapidescens 
significantly induces the gene expression o f IL - l ra (receptor antagonist), G-CSF 
and GM-CSF whereas schizophyllan from Schizophyllum commune strongly 
induces the production of mRNAs of IL-3 in ICR mice. It is suggested that the 
immunomodulating activities of antitumor glucans, OL-2 and schizophyllan, are 
different OSfemoto et al., 1993; Nemoto et al., 1994). In addition, the internal 
factors of the host also affect the gene expression of cytokines. When the gene 
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expression of cytokines in the ICR mice and the AKR mice which were a strain 
with a genetic C5 deficiency was compared by OL-2 administration, it was found 
that the changes in the gene expression of cytokines were less in the AKR mice. 
The finding indicates that the different characteristics of the immunomodulating 
activity of OL-2 between the ICR and AKR mice are closely related to the 
activation of the complement system (Nemoto et al., 1994). Moreover, the effect 
of antitumor polysaccharides on different types of cells is different. In the case of 
the peritoneal exudate cells (PEC) obtained from schizophyllan administered mice, 
the mRNAs ofn>- la, IL-2, IL-3 and TNF-a were increased while the mRNAs of 
JL-6 and M-CSF were decreased. In the case of spleen cells obtained from 
schizophyllan administered mice, there was only an increase in the mRNA levels 
for EL-la, IL - ip , JL-3 and IL-6 respectively. In the case of liver cells obtained 
from schizophyllan administered mice, the mRNAs of M-CSF, IL- lp , JL-3, IL-6 
and TNF-a were increased. Only IL-3 gene expression is induced in these three 
kinds of cells after schizophyllan administration in vivo fMemoto et al., 1994). The 
effect of PSK from Coriolus vericolor on the gene expression of cytokines of 
peripheral blood mononuclear cells (PBMC) is studied in vitro and in vivo. PSK 
induces the increase ofmRNA levels ofIL-8 and TNF-a ofPBMC in vitro (Hirose 
et al., 1990) and in vivo (Kato et al., 1995). However, the gene expression of 
TNF-a and IL-8 in PBMC of5 out of 12 volunteers is significantly increased after 
PSK administration. The results from the other 7 volunteers do not show any 
induction of gene expression for these cytokines. It seems that the responsiveness 
ofPBMC to PSK, in terms of gene expression and production of cytokines, varies 
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among individuals. Grifolan from Grifola frondosa increases the mRNA levels of 
n>-6, IL-1 and TNF-a of the macrophages from C3H/HeJ mice in vitro (Adachi et 
al., 1994). Therefore, the regulation of cytokine gene expression is a complicated 
problem. 
The cytokine regulation of the host immune responses has been widely 
studied. PSK increases the mRNA level of IL - ip , H^-lp activates natural killer 
cells and macrophages in vivo (Morinaga et al., 1994). However, not all of the 
cytokines increase the host immune responses. TGF_P is a bifunctional modulator 
of cell growth and differentiation, it can either stimulate or inhibit the proliferation 
of a variety of cell types. TGF-P inhibits the proliferation of human T and B 
lymphocytes (Micallef et al., 1994), and blocks the transition of pre-B to mature 
immunocompetent B cells. TGF-p gene expression of the tumor-bearing host is 
higher than that of the normal host. OL-2 glucan induces the gene expression of 
n , - l ra (receptor antagonist) in PEC ofICR mice fMemoto et al., 1993). IL- l ra is a 
naturally occurring antagonist o f I L - l a and IL - ip as it binds to IL- lR(I ) and H.-
lR(II). It is obvious that the cytokines are complicated regulating factors in vivo. 
Therefore, studies on gene expression of cytokines will help understand the 
antitumor and immunomodulating mechanism of polysaccharides. 
Since the cytokine genes are generally expressed only transiently, and at a 
low level, the conventional methods of mRNA analysis such as Northern and "dot 
blot" hybridization are not sensitive enough (Gilliland et al., 1990). Therefore, 
highly sensitive and quantitative methods are required to assess the gene 
expression of cytokines. The polymerase chain reaction (PCR) is the most well-
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known sensitive method to detect gene expression. The application of reverse 
transcription-polymerase chain reaction (RT-PCR) makes it possible to analyze 
small amounts of mRNA for the gene expression of cytokines (Taniguchi et al., 
1994). Although there are several methods to quantitate gene expression by PCR, 
the RT-PCR enzyme immunoassay is considered to be a rapid, sensitive and non-
radioactive method to quantitate cytokine mRNA. It is known that mushroom 
polysaccharides are multi-cytokine inducers. Therefore, RT-PCR enzyme 
immunoassay would be the best way to characterize the induction of gene 
expression of various cytokine by polysaccharides. 
In the previous chapter, it is found that PSPC elevates PEC and splenocyte 
activities at the cellular level. In this chapter, the gene expression of cytokines and 
cytokine receptors is examined using RT-PCR and dot-blot hybridization in 
response to PSPC and PSK in mice. The induction of gene expression by PSK is 
mainly used for comparison purpose. 
5.2. Materials and Methods 
5. 2. 1. Experimental animals 
Male inbred BALB/c mice (8-12 weeks old) were used in this study. The 
mice were divided into groups and housed under normal laboratory conditions (21 
士 2°C，12/12 h light-dark cycle) with free access to standard rodent chow and 
water. 
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5. 2. 2. Preparation ofperitoneal exudate cells and splenocytes 
A. Normal mice 
PSPC and PSK were injected intraperitoneally in mice for 10 consecutive 
days at the dose of 20 mgy'kg/day. The mice were sacrificed on the second day 
after completion of sample administration. Peritoneal exudate cells (PEC) were 
recovered by lavage of the peritoneal cavity with ice cold Hank's balanced salt 
solution (HBSS) and the splenocytes were obtained by homogenizing spleen with 
ice cold HBSS. The control group of mice was similarly treated with 0.9% NaCl 
solution. 
B. Tumor-bearing mice 
Sarcoma 180 cells were injected intraperitoneally and maintained in the 
peritoneum of male ICR mice. An ICR mouse was sacrificed on the seventh day 
after intraperitoneal inoculation ofSarcoma 180 and the ascitic fluid was collected. 
The cells were washed three times, and the cell suspension was diluted to lxlO^ 
cells/ml. Then, 0.1 ml (lxlO^ cells/ml) Sarcoma 180 cells were transplanted 
subcutaneously into the right groin of male BALB/c mice. The mice were 
sacrificed on the ten days after tumor transplantation. PEC and splenocytes were 
obtained. The control group of mice was similarly treated with 0.9% NaCl 
solution. 
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5. 2. 3. RNA extraction 
PEC and splenocytes of the mice were centrifuged at 5,000 rpm for 5 min 
respectively, and the supernatant was discarded. The cells were lysed in 4 M 
guanidinium thiocyanate (GT) solution containing 0.7% mercaptoethanol. The cell 
lysate was incubated at 65°C for 5 min, and put on ice at once for 5 min. 2.5 mI of 
cell lysate was overlaid to 1 ml of 5.7 M CsCl and subjected to ultracentrifugation 
at 18。C，32,000 rpm with SW 60 Ti rotor o fXL-80 ultracentrifuge for 18 h. The 
supernatant was discarded, and the RNA pellet was dissolved in 400^1 dd H2O, 
and then 45 ^il of 3 M NaAc and 1 ml ethanol were added. The RNA pellet was 
obtained after centrifugation at 15,000 rpm for 30 min and washed with ethanol. 
RNA concentration was determined by measuring the optical density at 260 nm. 
5. 2. 4. Reverse transcription-polymerase chain reaction 
A. Reverse transcription (RT) 
RNA sample was heated at 65°C for 5 min and reverse-transcribed at 37°C 
for 1 h in a 20 ^il reaction mix (for 1 [xg of total RNA) containing 40 units RNase 
inhibitor, 0.1 |ag oligo dT^-is, 0.5 mM of each dNTPs, 50 mM Tris-HCl pH 8.3， 
75 rnM KC1, 3 mM MgCb, 10 mM DTT and 200 units Moloney murine leukemia 




B. Polymerase chain reaction (PCR) 
The RT sample equivalent to 0.1 ^ig total RNA was boiled for 5 min and 
quickly chilled on ice. PCR cocktail was added to the RT sample to make up 50 ^il 
reaction mix containing 1.5 mM MgCb, 20 mM (NH4)2SO4, 75 mM Tris-HCl pH 
9.0, 0.01% Tween 20，0.2 mM of each dNTPs, 1 pmole/ml of each primers and 
0.25 units Thermoprime plus DNA polymerase (Thermoprime plus 207 G). PCR 
was performed for 35 cycles or as indicated, each cycle consisting of 1 min of 
denaturation at 94°C, 1 min of annealing at 56°C (or at 10°C below the melting 
temperature of primer) and 1 min of extension at 72°C. The reaction products 
were visualized by electrophoresis of lO^il reaction mixture at 100 V for 1 h in 
1.5% synergel and 0.7% agarose gel containing 0.5 jag/ml ethidium bromide. 1 kb 
DNA ladder (BRL) was mn in parallel as a molecular weight marker (providing 
main bands at 1018, 506, 396，344, 298, 220 and 201 bp). The glyceraldehyde-3-
phosphate-dehydrogenase (GAPDH, 452 bp), p-actin (650 bp) and J1 lD (328 bp) 
were used as standard in this study. Sequences of the PCR primers for IL-3R (A) 
and IL-3R (B) were described (Fung et al., 1992). Sequences of the PCR primers 
and the internal probes were shown in Table 5.1. 
5. 2. 5. Dot blot 
Ten microliters of each PCR product at different amplification cycles was 
denatured in 0.2 mM NaOH for 15 min before applied to the membrane 
(Boehringer Mannheim) assembled in the Dot-blot apparatus (Bio-Rad). Each well 
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Table 5.1. Sequences of the primers, and the internal probes used in RT-PCR and 
hybridization 
Cytokines/receptors Sequence (5' to 3') Size (bp) 
IL-1 a upper primer ACAGTATCAGCAACGTCAAGCAA 
lower primer CCGACTTTGTTCTTTGGTGGCA 546 
IL-1 P upper primer GAGCTTCAGGCAGGCAGTATC 
lower primer GTATAGATTCTTTCCTTTGAGGC 382 
IL-2 upper primer TTGATGGACCTACAGGAGCTCCTGAGCA 
lower primer AGAGAGCCTTATGTGTTGTAAGCAGGAGG 393 
IL-3 upper primer ATAGGGAAGCTCCCAGAACCTGAACTC 
lower primer AGACCCCTGGCAGCGCAGAGTCATTC 207 
IL-4 upper primer TGACGCACAGAGCTATTGATGG 
lower primer ATGATGCTCTTTAGGCTTTCCAG 422 
IL-5 upper primer TTGACAAGCAATGAGACGATGAG 
lower primer CAGTTTGAGGCCAGCCTGCG 507 
IL-6 upper primer TGACAAAAGAGTTGTGCAATGGC 
lower primer GAATGTCCACAAACTGATATGCTT 479 
IL-7 upper primer CACCCACCTCCCGCAGACC 
lower primer TGCATTTCTGTGTCCATCATCTC 639 
IL-10 upper primer TAGAGCTGCGGACTGCCTTCA 
lower primer TCATGGCCTTGTAGACACCTTG 351 
TNF-a upper primer TCCCCAAAGGGATGAGAAGTTC 
lower primer TCATACCAGGGTTTGAGCTCAG 411 




“ T N F - P upper primer“AGCCTTAATGGGTCTGGTTCTC 
lower primer TTGTTGCTCAAAGAGAAGCCATG 306 
IFN-y upper primer AGGAACTGGCAAAAGGATGGTG 
lower primer GTGCTGGCAGAATTATTCTTATTG 353 
GM-CSF upper primer TGGTCTACAGCCTCTCAGCAC 
lower primer AAGGGGATATCAGTCAGAAAGGT 364 
G-CSF upper primer ATCCAGGCCAGCGGCTCGG 
lower primer GGGCTTTCTGCTCAGGTCTAG 467 
M-CSF upper primer GTAGCCACATGATTGGGAATGG 
lower primer TCATGGAAAGTTCGGACACAGG 304 
internalprobe GTTCTGCTCCTCATAGTCCTTG 
TGF-P upper primer CATGGAGCTGGTGAAACGGAAGCGCATC 
lower primer CTCCAGTGACGTCAAAAGACAGCCACTC 497 
SCF upper primer CGAAGAGGCCAGAAACTAGATC 
lower primer GGGAATTTGTTTAAGGCTGCTTC 533 
IL-1R (I) upper primer ATGGAAGGGATGACTATGTTGGA . 
lower primer GCTGCAGCCTCTTATGATGGG 506 
IL-1 R(II) upper primer AAGGAACAACCACGGAACCCAT 
lower primer AGCCCTGCGTTTACACCGTCT 446 
IL-5R upper primer CATTAATGGCTCAAGCAAGCGTG 
lower primer ATGGCAAAATGCCATCAAAACGTG 630 
G-CSF R upper primer AGTCCTGGATGATAGAACCTAACGGGAAC 
lower primer TGCTCGACTGGTGGCCATGAGGTAGAC 395 
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was washed with 400 U^ of 20xSSC (3M NaCl, 0.3 M Na-citrate, pH 7.0). The 
membrane was baked for 30 min at 120°C. 
5. 2. 6. Hybridization 
The membrane was prehybridized at 10°C below melting temperature of 
the probe in 20 ml ofhybridization buffer (5xSSC, 1% w/v blocking reagent, 0.1% 
w/v N-lauroylsarkosine and 0.02% w/v SDS) for 4 h. The membrane was 
hybridized in 10 ml fresh hybridization buffer with the digoxigenin ddUTP labeled 
probe using the DIG oligonucleotide 3'-end labeling kit (Boehringer Mannheim) at 
10°C below melting temperature of the probe. The membrane was then washed 
2x15 min with 100 ml washing buffer (O.lM maleic acid, 0.15M NaCl, 0.3% 
Tween 20, pH 7.5) and equilibrated 5 min in the reaction buffer (O.lM Tris-HCl, 
O. lM NaCl, 50 mM MgCb, pH 9.5). Finally, the membrane was incubated in 
CSPD solution (Disodium 3- (4-methoxyspiro {l,2-dioxetane-3, 2，- (5，-chloro) 
tricyclo [3.3.1.l3.7] decan)-4yl) phenyl phosphate) for 5 min at room temperature, 
and sealed in a hybridization bag and incubated for 15 min at 37°C to enhance the 
luminescent reaction. The results were detected by exposing the hybridization 
qp* * 
membrane for 5 min at room temperature to X-OMAT AR (Kodak Scientific 
Film). The intensities of hybridization signals were analyzed using Molecular 
Analyst/PC system (Bio-Rad). 
141 
5. 3. Results 
5. 3. 1. mRNA phenotyping of cytokines and cytokine receptors in normal mice 
The detectable level of cytokine and cytokine receptor mRNAs was 
different between splenocytes and peritoneal exudate cells (PEC) of the mouse by 
RT-PCR. Nine out of seventeen cytokine mRNAs (Table 5.2) and five out of six 
cytokine receptor mRNAs (Table 5.3) were detected in the splenocytes and PEC 
from the control group and the treated groups of normal mice. However, IL-4 was 
only detected in the splenocytes while IL-7 and IL- lR(I ) were only detected in 
PEC. 
The use of RT-PCR products of control genes (GAPDH, P-actin and 
J l l D ; Fig. 5.1) would allow estimation of the mRNA level in the RT-PCR method 
in order to more precisely demonstrate the gene expression of cytokines by PSPC 
and PSK. Among nine cytokine genes, the expression level of M-CSF was up-
regulated in splenocytes (Fig. 5.2) and PEC (Fig. 5.3) of the mice by PSPC and 
PSK. The expression level of TNF-a was only up-regulated in PEC (Fig. 5.4) by 
PSK, but not byPSPC. 
5. 3. 2. mRNA phenotyping of cytokines and cytokine receptors in tumor-bearing 
mice 
In this experiment, GAPDH, p-actin and J l l D were used as controls (Fig. 
5.5). The mRNA level of TGF-P in splenocytes of the tumor-bearing mice was 
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Table 5.2. Detectable level of cytokine mRNA in the control group and treated 
groups of normal mice 
No. Cytokines Control PSPC PSK 
Splenocytes PEC Splenocytes PEC Splenocytes PEC 
1 TNF-a + + + + + + 
2 TNF-p - - - - - -
3 IFN-y + + + + + + 
4 IL- la - - 一 - 一 一 
5 IL-ip + + + + + + 
6 IL-2 + + + + + + 
7 IL-3 一 - 一 一 - 一 
8 IL-4 + - + - + -
9 IL-5 一 - 一 一 - -
10 IL-6 一 - 一 - 一 -
11 IL-7 - + - + - + 
12 IL-10 - - - - - -
13 TGF-P + + + + + + 
14 GM-CSF - - - - 一 -
15 G-CSF - - - - 一 -
16 M-CSF + + + + + + 
17 SCF + + + + + + 
PSPC and PSK were given intraperitoneaIly at the dose of 20 mg/kg/day for ten 
consecutive days in normal mice.The control group of mice was similarly treated 
with 0.9% NaCl solution. PEC stands for peritoneal exudate cells 
+: Detected 
一 ： N o t detected 
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Table 5.3. Detectable level of cytokine receptor mRNA in the control group and 
treated groups of normal mice 
No. Cytokine Control PSPC PSK 
receptors Splenocytes PEC Splenocytes PEC Splenocytes PEC 
1 I L - lR (I) - + - + - + 
2 I L - lR (II) + + + + + + 
3 I L - 3 R ( A ) + + + + + + 
4 n^-3R(B) + + + + + + 
5 IL-5 R 一 一 一 一 一 一 
6 G-CSF R + + + + + + 
PSPC and PSK were given intraperitoneally at the dose of 20 mg/kgAlay for ten 
consecutive days in normal mice. The control group of mice was similarly treated 
with 0.9% NaCl solution. PEC stands for peritoneal exudate cells. 
+: Detected 
- : N o t detected 
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Peritoneal exudate cells 
c b a d c b a d c b a 
M H H 
SBSWPl HHH 
• I 
p-actin J l lD GAPDH 
Splenocytes 
c b a d c b a d c b a d 
I I I 
p-actin J l lD GAPDH 
Fig. 5.1. RT-PCR products of p-actin, GAPDH and J1 l D at 35 cycles in 
peritoneal exudate cells and splenocytes from the control group 
and treated groups of normal mice. 
PSPC and PSK were given at the dose of 20 mg/kg/day for ten 
consecutive days in normal mice. The control group of mice was 
similarly treated with 0.9% NaCl solution, 
a. Control mice; b. PSPC-treated mice; c. PSK-treated mice; 
d. 1 kb marker (BRL). 
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c b a d 
IVolume P C R fOD X area (mm^)] 
a b c cycles a b c 
• • • 36 10.15 14.90 15.90 
• # # 32 4.43 7.89 6.54 
28 2.36 2.95 2.68 
24 1.98 2.18 2.18 
RT-PCR products Dot-blot hybridization of RT-PCR products 
at 35 cycles at different amplification cycles 
Fig. 5.2. M-CSF expression in splenocytes from the control group and treated 
groups of normal mice 
PSPC and PSK were given at the dose of 20 mg/kgAlay for ten 
consecutive days in normal mice. The control group of mice was 
similarly treated with 0.9% NaCl solution, 
a. Control mice; b. PSPC-treated mice; c. PSK-treated mice; 
d. 1 kb marker (BRL). 
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d a b c 
P ^ ^ ^ ^ | Volume 
^ ^ ^ ^ M P C R fOD X area (mm^)] 
|
a b c _ e s a b c 
• • • 24 2.93 4.75 8.25 
翁 • 22 1.95 3.06 3.10 
20 0.85 0.94 1.46 
18 1.08 0.98 1.20 
RT-PCR products Dot-blot hybridization of RT-PCR products 
at 35 cycles at different amplification cycles 
Fig. 5.3. M-CSF expression in peritoneal exudate cells from the control group 
and treated groups of normal mice 
PSPC and PSK were given at the dose of 20 mg/kg/day for ten 
consecutive days in normal mice. The control group of mice was 
similarly treated with 0.9% NaCl solution, 
a. Control mice; b. PSPC-treated mice; c. PSK-treated mice; 
d. 1 kb marker (BRL). 
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d c b a 
IVolume 
P C R fOD X area (mm^)l 
, cycles a b c 
a b c 
9 書 • 30 14.93 15.01 15,27 
• • • 24 5.32 5..80 11.99 
• 22 3.29 3.15 6.97 
* 20 2.29 2.41 4.21 
RT-PCR products Dot-blot hybridization ofRT-PCR products 
at 35 cycles at different amplification cycles 
Fig. 5.4. TNF-a expression in peritoneal exudate cells from the control group 
and treated groups of normal mice 
PSPC and PSK were given at the dose of 20 mg/kg/day for ten 
consecutive days in normal mice. The control group of mice was 
similarly treated with 0.9% NaCl solution, 
a. Control mice; b. PSPC-treated mice; c. PSK-treated mice; 
d. 1 kb marker (BRL). 
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Peritoneal exudate cells 
c b a a b c a b c 
I I I 
p-actin JllD G A P D H 
Splenocytes 
a b c c b a c b a 
III 
p-actin JllD G A P D H 
Fig. 5.5. RT-PCR products ofP-actin, GAPDH and J l l D at 35 cycles 
in peritoneal exudate cells and splenocytes from normal and 
tumor-bearing mice 
Mice were scarified two weeks after Sarcoma 180 subcutaneous 
implantation. 
a. 1 kb marker (BRL); b. Normal mice; c. Tumor-bearing mice. 
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higher more than that of the normal mice (Fig. 5.6). However, the mRNA level of 
TGF-P in PEC was not different between the normal and tumor-bearing mice. 
Apart from TGF-p, no significant differences of mRNA level were observed in 
other cytokines and cytokine receptors. 
5. 4. Discussion 
The expression level of M-CSF (macrophage-colony stimulating factor) is 
up-regulated in splenocytes and PEC of the mice by PSPC and PSK. M-CSF gene 
is located with cytokine cluster on the mouse chromosome 11. M-CSF is produced 
by a variety of cell types, including fibroblasts, monocytes, endothelial cells and T 
cells (Meager, 1990). In murine systems, M-CSF is a potent growth factor for 
bone marrow precursor cells and tissue macrophages. Pretreatment of monocytes 
with M-CSF significantly increases IFN-y-induced tumoricidal activity (Adam and 
Carlino, 1988; Vilcek and Le, 1992). M-CSF also stimulates mature macrophages 
to produce IL-1 and G-CSF, and enhances the tumoricidal, microbial killing and 
antiviral activities of macrophages. Since it is widely believed that the activated 
macrophages play an essential role in defense against tumor, M-CSF has been 
proposed as a therapeutic agent for treatment of tumor (Meager, 1990). The 
expression level of TNF-a (tumor necrosis factor-a) is only up-regulated by PSK 
in PEC of mice. TNF-a, which is the major cytokine product of activated 
macrophages, may enhance various functions of monocytes and macrophages, such 
as cytotoxicity to tumor cells. The mRNA level of TNF-a does not show 
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c b a a b c 
I I 
Splenocytes Peritoneal exudate cells 
Fig. 5.6 TGF-P expression in peritoneal exudate cells and splenocytes from 
normal and tumor-bearing mice 
Mice were scarified two weeks after Sarcoma 180 subcutaneous 
implantation. 
a. 1 kb marker (BRL); b. Normal mice; c. Tumor-bearing mice. 
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significant changes by PSPC administration. The result indicates that the effects of 
different polysaccharides on the gene expression of cytokines are different in mice. 
In the present experiment, the mRNA level of TGF_P in splenocytes of the 
Sarcoma 180-bearing mice is higher than that of the normal mice. It is reported 
that TGF-P inhibits the proliferation of human T and B lymphocytes (Kehrl et al., 
1986a; Kehrl et al., 1986b; Micallefet al., 1994). The addition ofexogenous TGF-
P to cultures o f T lymphocytes inhibits IL-2 dependent T cell proliferation. TGF-p 
is not toxic to the T cells, as judged by trypan blue dye exclusion. A potential 
mechanism whereby TGF-p suppresses T cell proliferation is by interfering with 
the normal regulation of IL-2R because the interaction of IL-2 with its receptor 
(IL-2R) on T cells has been shown to be of primary importance in T cell growth 
(Kehrl et al., 1986b). The effects ofTGF-p on B cell proliferation may explain that 
TGF-P induces suppression o f Ig secretion (Kehrl et al., 1986a). Some researches 
show that the supernatants of cultured spleen cells from the tumor-bearing mice 
contain up to eightfold more TGF-P than is found with the normal spleen cells. 
Therefore, certain tumors may escape an immune response by secreting large 
quantities of TGF-P in vivo (Berg et al., 1991). In this sense, TGF-p is an "anti-
cytokine" and may be a signal for shutting off immune responses (Abbas et al., 
1991). These researches at the molecular level are consistent with the study result 
of T cell mitogenic response at the cellular level (refer to Chapter 4). The T cell 
mitogenic activity of the Sarcoma 180-bearing mice is lower than that of the 
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normal mice. Thus, the suppression of T cells mitogenic activity in tumor-bearing 
mice might be attributed to the action ofTGF-p. 
5. 5. Summary 
PSPC exhibited a variety of immunomodulating actions both at the cellular 
and molecular levels. However, not all of the immunomodulating cytokines tested 
were activated by the antitumor polysaccharides. Different polysaccharides showed 
different effects on the gene expression of cytokines. In the present study, RNA 
samples were isolated from the splenocytes and peritoneal exudate cells of the 
control or treated mice, and reverse transcription-polymerase chain reaction (RT-
PCR) was used to analyze the gene expression of cytokines and cytokine 
receptors. Nine out of seventeen cytokine mRNAs and five out of six cytokine 
receptor mRNAs were detected in the splenocytes and peritoneal exudate cells 
from the control and treated mice. However, IL-4 was only detected in the 
splenocytes whereas IL-7 and IL- lR(I) were only detected in the peritoneal 
exudate cells. Among the nine cytokine genes, the gene expression level ofM-CSF 
was up-regulated in the splenocytes and the peritoneal exudate cells of mice by 
PSPC and PSK. The gene expression level ofTNF-a was only up-regulated in the 
peritoneal exudate cells by PSK, but not by PSPC. The mRNA level ofTGF-p in 
the splenocytes of tumor-bearing mice was higher than that of the normal mice. 
These results indicated that the induction of gene expression of cytokines by 
antitumor polysaccharides was quite complicated. Therefore, the kinetic 
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experiments of gene expression of cytokines and cytokine receptors might be 




General Discussion and Conclusion 
In screening for pharmacologically active components of the local 
mushroom sources’ Tricholoma lobayeme Heim is found to contain a 
polysaccharide-protein complex (PSPC) with antitumor and immunopotentiating 
activities. PSPC is a protein-bound polysaccharide, with a molecular mass 
estimated to be 154 kDa. It consists of 54.3% polysaccharide and 35.9% protein. 
The characteristic primary molecular groups of polysaccharide and intermolecular 
hydrogen bonds are elicited in PSPC. The composition, characteristic structure and 
antitumor activity ofPSPC are similar to those ofPSK which is a commercially 
available antitumor agent from the cultured mycelia of Cohohis versicolor in Japan 
(Tsukagoshi et al.，1984). PSK is obtained from Coriolus versicolor by hot water 
extraction of the mycelia followed by saturated ammonium sulfate precipitation 
and desalted by dialysis against water. PSPC of the present study is directly 
isolated from the culture filtrates of T, lohayense with ethanol precipitation. 
Therefore, PSPC appears to be more suitable for a large scale production. 
Schizophyllan is another commercially available antitumor agent from the culture 
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filtrates ofSchizophyIhmi comnnme in Japan (Komatsu et al., 1969). It is a pure P_ 
glucan and its biological activity is different from those of PSPC and PSK. The 
、 characteristic odor ofits culture filtrates is unpleasant and thus makes it 口叩0口口仏厂. 
Lentinan is also a commercially available antitumor agent from the fruiting body of 
Lentinus edodes in Japan (Chihara et al., 1969). However, it is hardly soluble in 
water without autoclaving, and it can be administered only by one route, i.e. 
intravenous injection. Therefore, PSPC deserves further research for potential 
development as a nutriceutical or as an immunomodulating adjuvant for 
chemotherapy of cancer. 
PSPC could inhibit the growth of Sarcoma 180 implanted in the mice 
intraperitoneally and subcutaneously, with no sign of toxicity in vivo. At the 
cellular level, it was found that PSPC could restore and increase the phagocytic 
function ofperitoneal exudate cells (PEC) and the mitogenic response o fT cells of 
the tumor-bearing mice, and exhibited indirect cytotoxicity against P815 cells and 
L929 cells by activating PEC to release the mediators, such as nitric oxide and 
TNF-a. In addition, PSPC indirectly induced apoptosis of Sarcoma 180 in vivo, 
and directly induced apoptosis of HL-60 cells in vitro. The direct in vitro 
cytotoxicity ofPSPC was also observed in PU5-1.8, H3B and melanoma tumor 
cell lines. Hence, the antitumor activity of PSPC might be due to both host-
mediated immunomodulating action and direct cytotoxicity. 
Seventeen cytokines and six cytokine receptors were assessed in the 
splenocytes and PEC of mice. Nine out of seventeen cytokine mRNAs and five out 
ofsix cytokine receptor mRNAs were detected in the splenocytes and PEC ofboth 
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the control and treated mice. However, IL-4 was only detected in the splenocytes 
while IL-7 and IL- lR(I ) were only detected in the PEC. Among nine cytokine 
、 
genes, the expression level of M-CSF was up-regulated in the splenocytes and 
PEC ofthe mice by PSPC. It is concluded that the antitumor mechanism ofPSPC 
is likely via cytokine potentiation pathways. 
The present studies show that the levels of gene expression of only M-CSF 
and TNF-a induced by PSPC and PSK change significantly as compared to those 
ofthe control. The mRNA levels of other cytokines and cytokine receptors tested 
are not affected by PSPC and PSK. Nevertheless, it might be incorrect to draw a 
conclusion that these cytokines and cytokine receptors are not inducible by 
polysaccharides only from these results. Some reports indicate that the mRNA 
levels of cytokines in the organs and cells are controlled by the rates of both 
synthesis and degradation of cytokines CNemoto et al., 1994). It is found that the 
kinetics of cytokine gene expression is dependent on the type of cytokine and the 
organ, as well as time lapse after polysaccharide treatment. In the kinetic 
experiment, the mRNA level ofM-CSF is increased at around a week after OL-2 
glucan administration in PEC, whereas the mRNA level o f IL-2 is increased at 1 h 
and remains high for a day after schizophyllan administration in PEC P^emoto et 
al.，1994). The mRNA level o f I L - i p shows an increase in 2-6 h, and returns to its 
baseline level 24 h after PSK administration in the spleen and liver (Morinaga et 
al., 1994). In my study, the mRNA levels of cytokines and cytokine receptors 
were detected at 24 h after the completion ofPSPC and PSK administration for 10 
consecutive days. Therefore, it is possible that some changes of gene expression of 
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cytokines and cytokine receptors by PSPC and PSK are not observed. The future 
research should focus on the kinetic experiments of cytokine gene expression, such 
as the gene expression of cytokines at different times and in the specific organs 
after PSPC administration. A thorough understanding of immunomodulating 
actions of PSPC at the cellular and molecular levels will help to elucidate its 
antitumor mechanism. 
In the present study, the antimicrobial, free radical scavenging and hepatic 
protective effects ofPSPC were also evaluated. PSPC has the potent antimicrobial 
activity against Escherichia coli B and Staphylococcus aureus by the activation of 
phagocytic function and nitric oxide production of the macrophages. It exhibits the 
scavenging activities on superoxide and hydroxyl radicals generated in vitro. PSPC 
also shows some antifatigue action in vivo. Therefore, PSPC is a promising 
pharmacologically active component from the local mushroom. 
Although new insights into the antitumor mechanism of polysaccharides 
have been elicited during the past several years, further researches are still needed 
for a thorough understanding of modes of action of these potentially important 
nutriceutical or pharmaceutical substances. 
Further studies of the promising polysaccharide-protein complex (PSPC) 
should focus on investigation of the relationship between its structure and 
antitumor activity, elucidation of its antitumor mechanism at the molecular level, 
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